JP2002323728A - Processing method for silver halide photographic sensitive material - Google Patents
Processing method for silver halide photographic sensitive materialInfo
- Publication number
- JP2002323728A JP2002323728A JP2001125795A JP2001125795A JP2002323728A JP 2002323728 A JP2002323728 A JP 2002323728A JP 2001125795 A JP2001125795 A JP 2001125795A JP 2001125795 A JP2001125795 A JP 2001125795A JP 2002323728 A JP2002323728 A JP 2002323728A
- Authority
- JP
- Japan
- Prior art keywords
- silver halide
- halide photographic
- processing
- group
- solution
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- -1 silver halide Chemical class 0.000 title claims abstract description 114
- 229910052709 silver Inorganic materials 0.000 title claims abstract description 101
- 239000004332 silver Substances 0.000 title claims abstract description 101
- 239000000463 material Substances 0.000 title claims abstract description 94
- 238000003672 processing method Methods 0.000 title claims abstract description 19
- 238000012545 processing Methods 0.000 claims abstract description 108
- 150000001875 compounds Chemical class 0.000 claims abstract description 46
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 43
- 239000000839 emulsion Substances 0.000 claims abstract description 38
- 238000005406 washing Methods 0.000 claims abstract description 17
- 238000000034 method Methods 0.000 claims description 51
- 239000003795 chemical substances by application Substances 0.000 claims description 42
- 239000007787 solid Substances 0.000 claims description 41
- 239000000084 colloidal system Substances 0.000 claims description 17
- 125000005647 linker group Chemical group 0.000 claims description 11
- 230000008961 swelling Effects 0.000 claims description 11
- 229910052782 aluminium Inorganic materials 0.000 claims description 9
- 125000004432 carbon atom Chemical group C* 0.000 claims description 8
- 150000003863 ammonium salts Chemical class 0.000 claims description 7
- 150000001639 boron compounds Chemical class 0.000 claims description 7
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 7
- 125000000129 anionic group Chemical group 0.000 claims description 6
- 125000002091 cationic group Chemical group 0.000 claims description 6
- 229910052757 nitrogen Inorganic materials 0.000 claims description 6
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 claims description 5
- 229910052731 fluorine Inorganic materials 0.000 claims description 5
- 125000001153 fluoro group Chemical group F* 0.000 claims description 4
- 125000001931 aliphatic group Chemical group 0.000 claims description 3
- 125000004433 nitrogen atom Chemical group N* 0.000 claims description 3
- 125000004430 oxygen atom Chemical group O* 0.000 claims description 3
- 125000005010 perfluoroalkyl group Chemical group 0.000 claims description 3
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 abstract description 23
- 230000007547 defect Effects 0.000 abstract description 21
- 239000010802 sludge Substances 0.000 abstract description 12
- 239000013078 crystal Substances 0.000 abstract description 8
- 238000003745 diagnosis Methods 0.000 abstract description 6
- 230000002829 reductive effect Effects 0.000 abstract description 4
- 230000002035 prolonged effect Effects 0.000 abstract description 2
- 239000000243 solution Substances 0.000 description 84
- 239000010410 layer Substances 0.000 description 34
- 108010010803 Gelatin Proteins 0.000 description 31
- 229920000159 gelatin Polymers 0.000 description 31
- 239000008273 gelatin Substances 0.000 description 31
- 235000019322 gelatine Nutrition 0.000 description 31
- 235000011852 gelatine desserts Nutrition 0.000 description 31
- 239000011734 sodium Substances 0.000 description 31
- 239000000047 product Substances 0.000 description 21
- 238000002360 preparation method Methods 0.000 description 19
- 230000000694 effects Effects 0.000 description 17
- 239000008187 granular material Substances 0.000 description 16
- 239000000126 substance Substances 0.000 description 16
- 238000001035 drying Methods 0.000 description 15
- 206010070834 Sensitisation Diseases 0.000 description 13
- 238000011161 development Methods 0.000 description 13
- 239000007788 liquid Substances 0.000 description 13
- 230000008313 sensitization Effects 0.000 description 13
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 12
- 239000000975 dye Substances 0.000 description 12
- IOLCXVTUBQKXJR-UHFFFAOYSA-M potassium bromide Chemical compound [K+].[Br-] IOLCXVTUBQKXJR-UHFFFAOYSA-M 0.000 description 12
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Chemical compound [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 description 12
- 238000011156 evaluation Methods 0.000 description 11
- 238000005469 granulation Methods 0.000 description 11
- 230000003179 granulation Effects 0.000 description 11
- 239000002245 particle Substances 0.000 description 11
- 239000000843 powder Substances 0.000 description 11
- 238000002156 mixing Methods 0.000 description 10
- 241000287828 Gallus gallus Species 0.000 description 9
- 229910052739 hydrogen Inorganic materials 0.000 description 9
- 238000003756 stirring Methods 0.000 description 9
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 8
- 229910021612 Silver iodide Inorganic materials 0.000 description 8
- LSNNMFCWUKXFEE-UHFFFAOYSA-N Sulfurous acid Chemical compound OS(O)=O LSNNMFCWUKXFEE-UHFFFAOYSA-N 0.000 description 8
- 239000007864 aqueous solution Substances 0.000 description 8
- 238000006243 chemical reaction Methods 0.000 description 8
- 239000000203 mixture Substances 0.000 description 8
- JKFYKCYQEWQPTM-UHFFFAOYSA-N 2-azaniumyl-2-(4-fluorophenyl)acetate Chemical compound OC(=O)C(N)C1=CC=C(F)C=C1 JKFYKCYQEWQPTM-UHFFFAOYSA-N 0.000 description 7
- 229920001477 hydrophilic polymer Polymers 0.000 description 7
- 230000005070 ripening Effects 0.000 description 7
- 229910052711 selenium Inorganic materials 0.000 description 7
- 239000011669 selenium Substances 0.000 description 7
- 229940045105 silver iodide Drugs 0.000 description 7
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 6
- 230000005540 biological transmission Effects 0.000 description 6
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 6
- 230000001235 sensitizing effect Effects 0.000 description 6
- GEHJYWRUCIMESM-UHFFFAOYSA-L sodium sulfite Chemical compound [Na+].[Na+].[O-]S([O-])=O GEHJYWRUCIMESM-UHFFFAOYSA-L 0.000 description 6
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 5
- 239000002253 acid Substances 0.000 description 5
- 125000002947 alkylene group Chemical group 0.000 description 5
- 239000011230 binding agent Substances 0.000 description 5
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 5
- 239000012153 distilled water Substances 0.000 description 5
- 150000003839 salts Chemical class 0.000 description 5
- 229910052708 sodium Inorganic materials 0.000 description 5
- 235000008733 Citrus aurantifolia Nutrition 0.000 description 4
- 229920000858 Cyclodextrin Polymers 0.000 description 4
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 4
- CIWBSHSKHKDKBQ-DUZGATOHSA-N D-araboascorbic acid Natural products OC[C@@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-DUZGATOHSA-N 0.000 description 4
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 4
- 229920002307 Dextran Polymers 0.000 description 4
- QIGBRXMKCJKVMJ-UHFFFAOYSA-N Hydroquinone Chemical compound OC1=CC=C(O)C=C1 QIGBRXMKCJKVMJ-UHFFFAOYSA-N 0.000 description 4
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 4
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 4
- 235000011941 Tilia x europaea Nutrition 0.000 description 4
- ISAKRJDGNUQOIC-UHFFFAOYSA-N Uracil Chemical compound O=C1C=CNC(=O)N1 ISAKRJDGNUQOIC-UHFFFAOYSA-N 0.000 description 4
- 238000007906 compression Methods 0.000 description 4
- 230000006835 compression Effects 0.000 description 4
- 235000010350 erythorbic acid Nutrition 0.000 description 4
- 239000004318 erythorbic acid Substances 0.000 description 4
- 229940026239 isoascorbic acid Drugs 0.000 description 4
- 239000004571 lime Substances 0.000 description 4
- CMCWWLVWPDLCRM-UHFFFAOYSA-N phenidone Chemical compound N1C(=O)CCN1C1=CC=CC=C1 CMCWWLVWPDLCRM-UHFFFAOYSA-N 0.000 description 4
- 239000004848 polyfunctional curative Substances 0.000 description 4
- 229920000642 polymer Polymers 0.000 description 4
- 239000003755 preservative agent Substances 0.000 description 4
- 230000002335 preservative effect Effects 0.000 description 4
- 229940065287 selenium compound Drugs 0.000 description 4
- 150000003343 selenium compounds Chemical class 0.000 description 4
- ADZWSOLPGZMUMY-UHFFFAOYSA-M silver bromide Chemical compound [Ag]Br ADZWSOLPGZMUMY-UHFFFAOYSA-M 0.000 description 4
- SQGYOTSLMSWVJD-UHFFFAOYSA-N silver(1+) nitrate Chemical compound [Ag+].[O-]N(=O)=O SQGYOTSLMSWVJD-UHFFFAOYSA-N 0.000 description 4
- MNNBCKASUFBXCO-UHFFFAOYSA-N 2-acetamido-3-methyl-3-sulfanylbutanoic acid Chemical compound CC(=O)NC(C(O)=O)C(C)(C)S MNNBCKASUFBXCO-UHFFFAOYSA-N 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 3
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 3
- QPCDCPDFJACHGM-UHFFFAOYSA-N N,N-bis{2-[bis(carboxymethyl)amino]ethyl}glycine Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(=O)O)CCN(CC(O)=O)CC(O)=O QPCDCPDFJACHGM-UHFFFAOYSA-N 0.000 description 3
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 3
- 239000003513 alkali Substances 0.000 description 3
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 3
- XYXNTHIYBIDHGM-UHFFFAOYSA-N ammonium thiosulfate Chemical compound [NH4+].[NH4+].[O-]S([O-])(=O)=S XYXNTHIYBIDHGM-UHFFFAOYSA-N 0.000 description 3
- 239000003963 antioxidant agent Substances 0.000 description 3
- 235000006708 antioxidants Nutrition 0.000 description 3
- 125000000732 arylene group Chemical group 0.000 description 3
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 description 3
- 239000004327 boric acid Substances 0.000 description 3
- 239000000872 buffer Substances 0.000 description 3
- 239000002738 chelating agent Substances 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 238000000576 coating method Methods 0.000 description 3
- 238000002425 crystallisation Methods 0.000 description 3
- 230000008025 crystallization Effects 0.000 description 3
- YGZZDQOCTFVBFC-UHFFFAOYSA-L disodium;1,5-dihydroxypentane-1,5-disulfonate Chemical compound [Na+].[Na+].[O-]S(=O)(=O)C(O)CCCC(O)S([O-])(=O)=O YGZZDQOCTFVBFC-UHFFFAOYSA-L 0.000 description 3
- 235000010355 mannitol Nutrition 0.000 description 3
- 239000003960 organic solvent Substances 0.000 description 3
- 239000006187 pill Substances 0.000 description 3
- 235000015497 potassium bicarbonate Nutrition 0.000 description 3
- 239000011736 potassium bicarbonate Substances 0.000 description 3
- 229910000028 potassium bicarbonate Inorganic materials 0.000 description 3
- 229910000027 potassium carbonate Inorganic materials 0.000 description 3
- 235000011181 potassium carbonates Nutrition 0.000 description 3
- TYJJADVDDVDEDZ-UHFFFAOYSA-M potassium hydrogencarbonate Chemical compound [K+].OC([O-])=O TYJJADVDDVDEDZ-UHFFFAOYSA-M 0.000 description 3
- 239000001632 sodium acetate Substances 0.000 description 3
- 235000017281 sodium acetate Nutrition 0.000 description 3
- HRZFUMHJMZEROT-UHFFFAOYSA-L sodium disulfite Chemical compound [Na+].[Na+].[O-]S(=O)S([O-])(=O)=O HRZFUMHJMZEROT-UHFFFAOYSA-L 0.000 description 3
- 229940001584 sodium metabisulfite Drugs 0.000 description 3
- 235000010262 sodium metabisulphite Nutrition 0.000 description 3
- 159000000000 sodium salts Chemical class 0.000 description 3
- 235000010265 sodium sulphite Nutrition 0.000 description 3
- 239000003381 stabilizer Substances 0.000 description 3
- 239000007858 starting material Substances 0.000 description 3
- 239000004094 surface-active agent Substances 0.000 description 3
- LWIHDJKSTIGBAC-UHFFFAOYSA-K tripotassium phosphate Chemical compound [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 3
- XBYRMPXUBGMOJC-UHFFFAOYSA-N 1,2-dihydropyrazol-3-one Chemical compound OC=1C=CNN=1 XBYRMPXUBGMOJC-UHFFFAOYSA-N 0.000 description 2
- GGZHVNZHFYCSEV-UHFFFAOYSA-N 1-Phenyl-5-mercaptotetrazole Chemical compound SC1=NN=NN1C1=CC=CC=C1 GGZHVNZHFYCSEV-UHFFFAOYSA-N 0.000 description 2
- GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 2
- 229930024421 Adenine Natural products 0.000 description 2
- BZKFMUIJRXWWQK-UHFFFAOYSA-N Cyclopentenone Chemical compound O=C1CCC=C1 BZKFMUIJRXWWQK-UHFFFAOYSA-N 0.000 description 2
- 229920001353 Dextrin Polymers 0.000 description 2
- 239000004375 Dextrin Substances 0.000 description 2
- NVXLIZQNSVLKPO-UHFFFAOYSA-N Glucosereductone Chemical compound O=CC(O)C=O NVXLIZQNSVLKPO-UHFFFAOYSA-N 0.000 description 2
- 229930195725 Mannitol Natural products 0.000 description 2
- 238000001016 Ostwald ripening Methods 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical group OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 2
- NPYPAHLBTDXSSS-UHFFFAOYSA-N Potassium ion Chemical compound [K+] NPYPAHLBTDXSSS-UHFFFAOYSA-N 0.000 description 2
- FKNQFGJONOIPTF-UHFFFAOYSA-N Sodium cation Chemical compound [Na+] FKNQFGJONOIPTF-UHFFFAOYSA-N 0.000 description 2
- ABBQHOQBGMUPJH-UHFFFAOYSA-M Sodium salicylate Chemical compound [Na+].OC1=CC=CC=C1C([O-])=O ABBQHOQBGMUPJH-UHFFFAOYSA-M 0.000 description 2
- 229920002125 Sokalan® Polymers 0.000 description 2
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 2
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 2
- OXMKNUCRSLQWMI-UHFFFAOYSA-N Tetrahydropyridone Natural products O=C1CCCC=N1 OXMKNUCRSLQWMI-UHFFFAOYSA-N 0.000 description 2
- ZJCCRDAZUWHFQH-UHFFFAOYSA-N Trimethylolpropane Chemical compound CCC(CO)(CO)CO ZJCCRDAZUWHFQH-UHFFFAOYSA-N 0.000 description 2
- 229960000643 adenine Drugs 0.000 description 2
- 125000005210 alkyl ammonium group Chemical group 0.000 description 2
- 125000000217 alkyl group Chemical group 0.000 description 2
- 125000004656 alkyl sulfonylamino group Chemical group 0.000 description 2
- DIZPMCHEQGEION-UHFFFAOYSA-H aluminium sulfate (anhydrous) Chemical compound [Al+3].[Al+3].[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O DIZPMCHEQGEION-UHFFFAOYSA-H 0.000 description 2
- 125000003277 amino group Chemical group 0.000 description 2
- 150000001450 anions Chemical class 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- 125000004657 aryl sulfonyl amino group Chemical group 0.000 description 2
- 235000010323 ascorbic acid Nutrition 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 230000000903 blocking effect Effects 0.000 description 2
- 150000001768 cations Chemical class 0.000 description 2
- 239000003638 chemical reducing agent Substances 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- JHIVVAPYMSGYDF-UHFFFAOYSA-N cyclohexanone Chemical compound O=C1CCCCC1 JHIVVAPYMSGYDF-UHFFFAOYSA-N 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 235000019425 dextrin Nutrition 0.000 description 2
- 150000005205 dihydroxybenzenes Chemical class 0.000 description 2
- 239000006185 dispersion Substances 0.000 description 2
- 238000009826 distribution Methods 0.000 description 2
- 239000010419 fine particle Substances 0.000 description 2
- 229910052736 halogen Inorganic materials 0.000 description 2
- 150000002367 halogens Chemical class 0.000 description 2
- 239000003112 inhibitor Substances 0.000 description 2
- GLXDVVHUTZTUQK-UHFFFAOYSA-M lithium;hydroxide;hydrate Chemical compound [Li+].O.[OH-] GLXDVVHUTZTUQK-UHFFFAOYSA-M 0.000 description 2
- 239000000594 mannitol Substances 0.000 description 2
- 229910021645 metal ion Inorganic materials 0.000 description 2
- 229910000510 noble metal Inorganic materials 0.000 description 2
- 238000010899 nucleation Methods 0.000 description 2
- 230000006911 nucleation Effects 0.000 description 2
- JOXIMZWYDAKGHI-UHFFFAOYSA-N p-toluenesulfonic acid Substances CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 2
- 229960003330 pentetic acid Drugs 0.000 description 2
- 229920000139 polyethylene terephthalate Polymers 0.000 description 2
- 239000005020 polyethylene terephthalate Substances 0.000 description 2
- 229910052700 potassium Inorganic materials 0.000 description 2
- 239000011591 potassium Substances 0.000 description 2
- 229910001414 potassium ion Inorganic materials 0.000 description 2
- ZJEFVRRDAORHKG-UHFFFAOYSA-M potassium;2-hydroxy-5-sulfobenzoate Chemical compound [K+].OC1=CC=C(S(O)(=O)=O)C=C1C([O-])=O ZJEFVRRDAORHKG-UHFFFAOYSA-M 0.000 description 2
- 239000011241 protective layer Substances 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 150000003346 selenoethers Chemical class 0.000 description 2
- 229910001961 silver nitrate Inorganic materials 0.000 description 2
- 229910000029 sodium carbonate Inorganic materials 0.000 description 2
- 235000017550 sodium carbonate Nutrition 0.000 description 2
- 229910001415 sodium ion Inorganic materials 0.000 description 2
- AKHNMLFCWUSKQB-UHFFFAOYSA-L sodium thiosulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=S AKHNMLFCWUSKQB-UHFFFAOYSA-L 0.000 description 2
- 235000019345 sodium thiosulphate Nutrition 0.000 description 2
- QWSZRRAAFHGKCH-UHFFFAOYSA-M sodium;hexane-1-sulfonate Chemical compound [Na+].CCCCCCS([O-])(=O)=O QWSZRRAAFHGKCH-UHFFFAOYSA-M 0.000 description 2
- HRQDCDQDOPSGBR-UHFFFAOYSA-M sodium;octane-1-sulfonate Chemical compound [Na+].CCCCCCCCS([O-])(=O)=O HRQDCDQDOPSGBR-UHFFFAOYSA-M 0.000 description 2
- 230000003595 spectral effect Effects 0.000 description 2
- 238000006467 substitution reaction Methods 0.000 description 2
- 125000000542 sulfonic acid group Chemical group 0.000 description 2
- 229910052717 sulfur Inorganic materials 0.000 description 2
- 239000011593 sulfur Substances 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 230000002194 synthesizing effect Effects 0.000 description 2
- 239000008399 tap water Substances 0.000 description 2
- 235000020679 tap water Nutrition 0.000 description 2
- 239000011975 tartaric acid Substances 0.000 description 2
- 235000002906 tartaric acid Nutrition 0.000 description 2
- 229910052714 tellurium Inorganic materials 0.000 description 2
- PORWMNRCUJJQNO-UHFFFAOYSA-N tellurium atom Chemical compound [Te] PORWMNRCUJJQNO-UHFFFAOYSA-N 0.000 description 2
- DHCDFWKWKRSZHF-UHFFFAOYSA-L thiosulfate(2-) Chemical compound [O-]S([S-])(=O)=O DHCDFWKWKRSZHF-UHFFFAOYSA-L 0.000 description 2
- ZFVJLNKVUKIPPI-UHFFFAOYSA-N triphenyl(selanylidene)-$l^{5}-phosphane Chemical compound C=1C=CC=CC=1P(C=1C=CC=CC=1)(=[Se])C1=CC=CC=C1 ZFVJLNKVUKIPPI-UHFFFAOYSA-N 0.000 description 2
- 229940035893 uracil Drugs 0.000 description 2
- 239000004034 viscosity adjusting agent Substances 0.000 description 2
- YZOUYRAONFXZSI-SBHWVFSVSA-N (1S,3R,5R,6R,8R,10R,11R,13R,15R,16R,18R,20R,21R,23R,25R,26R,28R,30R,31S,33R,35R,36R,37S,38R,39S,40R,41S,42R,43S,44R,45S,46R,47S,48R,49S)-5,10,15,20,25,30,35-heptakis(hydroxymethyl)-37,39,40,41,42,43,44,45,46,47,48,49-dodecamethoxy-2,4,7,9,12,14,17,19,22,24,27,29,32,34-tetradecaoxaoctacyclo[31.2.2.23,6.28,11.213,16.218,21.223,26.228,31]nonatetracontane-36,38-diol Chemical compound O([C@@H]([C@H]([C@@H]1OC)OC)O[C@H]2[C@@H](O)[C@@H]([C@@H](O[C@@H]3[C@@H](CO)O[C@@H]([C@H]([C@@H]3O)OC)O[C@@H]3[C@@H](CO)O[C@@H]([C@H]([C@@H]3OC)OC)O[C@@H]3[C@@H](CO)O[C@@H]([C@H]([C@@H]3OC)OC)O[C@@H]3[C@@H](CO)O[C@@H]([C@H]([C@@H]3OC)OC)O3)O[C@@H]2CO)OC)[C@H](CO)[C@H]1O[C@@H]1[C@@H](OC)[C@H](OC)[C@H]3[C@@H](CO)O1 YZOUYRAONFXZSI-SBHWVFSVSA-N 0.000 description 1
- WFNHDWNSTLRUOC-UHFFFAOYSA-M (2-nitrophenyl)-triphenylphosphanium;chloride Chemical compound [Cl-].[O-][N+](=O)C1=CC=CC=C1[P+](C=1C=CC=CC=1)(C=1C=CC=CC=1)C1=CC=CC=C1 WFNHDWNSTLRUOC-UHFFFAOYSA-M 0.000 description 1
- QGKMIGUHVLGJBR-UHFFFAOYSA-M (4z)-1-(3-methylbutyl)-4-[[1-(3-methylbutyl)quinolin-1-ium-4-yl]methylidene]quinoline;iodide Chemical compound [I-].C12=CC=CC=C2N(CCC(C)C)C=CC1=CC1=CC=[N+](CCC(C)C)C2=CC=CC=C12 QGKMIGUHVLGJBR-UHFFFAOYSA-M 0.000 description 1
- OMAWWKIPXLIPDE-UHFFFAOYSA-N (ethyldiselanyl)ethane Chemical compound CC[Se][Se]CC OMAWWKIPXLIPDE-UHFFFAOYSA-N 0.000 description 1
- HMXQIFUGFZEJEO-UHFFFAOYSA-N 1,2-dihydropyrrol-3-one Chemical compound O=C1CNC=C1 HMXQIFUGFZEJEO-UHFFFAOYSA-N 0.000 description 1
- RVXJIYJPQXRIEM-UHFFFAOYSA-N 1-$l^{1}-selanyl-n,n-dimethylmethanimidamide Chemical compound CN(C)C([Se])=N RVXJIYJPQXRIEM-UHFFFAOYSA-N 0.000 description 1
- FXEIVSYQEOJLBU-UHFFFAOYSA-N 1-$l^{1}-selanylethanimine Chemical compound CC([Se])=N FXEIVSYQEOJLBU-UHFFFAOYSA-N 0.000 description 1
- BAXOFTOLAUCFNW-UHFFFAOYSA-N 1H-indazole Chemical compound C1=CC=C2C=NNC2=C1 BAXOFTOLAUCFNW-UHFFFAOYSA-N 0.000 description 1
- AEQDJSLRWYMAQI-UHFFFAOYSA-N 2,3,9,10-tetramethoxy-6,8,13,13a-tetrahydro-5H-isoquinolino[2,1-b]isoquinoline Chemical compound C1CN2CC(C(=C(OC)C=C3)OC)=C3CC2C2=C1C=C(OC)C(OC)=C2 AEQDJSLRWYMAQI-UHFFFAOYSA-N 0.000 description 1
- JBAITADHMBPOQQ-UHFFFAOYSA-N 2-(1h-benzimidazol-2-yl)-1,3-thiazole Chemical compound C1=CSC(C=2NC3=CC=CC=C3N=2)=N1 JBAITADHMBPOQQ-UHFFFAOYSA-N 0.000 description 1
- QADPIHSGFPJNFS-UHFFFAOYSA-N 2-(1h-benzimidazol-2-ylmethyl)-1,3-thiazole Chemical compound N=1C2=CC=CC=C2NC=1CC1=NC=CS1 QADPIHSGFPJNFS-UHFFFAOYSA-N 0.000 description 1
- JHKKTXXMAQLGJB-UHFFFAOYSA-N 2-(methylamino)phenol Chemical compound CNC1=CC=CC=C1O JHKKTXXMAQLGJB-UHFFFAOYSA-N 0.000 description 1
- XNWFRZJHXBZDAG-UHFFFAOYSA-N 2-METHOXYETHANOL Chemical compound COCCO XNWFRZJHXBZDAG-UHFFFAOYSA-N 0.000 description 1
- CDAWCLOXVUBKRW-UHFFFAOYSA-N 2-aminophenol Chemical class NC1=CC=CC=C1O CDAWCLOXVUBKRW-UHFFFAOYSA-N 0.000 description 1
- IQMGXSMKUXLLER-UHFFFAOYSA-N 2-hydroxy-5-sulfobenzoic acid;sodium Chemical compound [Na].OC(=O)C1=CC(S(O)(=O)=O)=CC=C1O IQMGXSMKUXLLER-UHFFFAOYSA-N 0.000 description 1
- ZPSJGADGUYYRKE-UHFFFAOYSA-N 2H-pyran-2-one Chemical compound O=C1C=CC=CO1 ZPSJGADGUYYRKE-UHFFFAOYSA-N 0.000 description 1
- PLIKAWJENQZMHA-UHFFFAOYSA-N 4-aminophenol Chemical class NC1=CC=C(O)C=C1 PLIKAWJENQZMHA-UHFFFAOYSA-N 0.000 description 1
- SRPOQCIVIBFKEQ-UHFFFAOYSA-N 4-oxo-4-pentadecoxy-3-sulfobutanoic acid Chemical compound CCCCCCCCCCCCCCCOC(=O)C(S(O)(=O)=O)CC(O)=O SRPOQCIVIBFKEQ-UHFFFAOYSA-N 0.000 description 1
- PZBQVZFITSVHAW-UHFFFAOYSA-N 5-chloro-2h-benzotriazole Chemical compound C1=C(Cl)C=CC2=NNN=C21 PZBQVZFITSVHAW-UHFFFAOYSA-N 0.000 description 1
- LRUDIIUSNGCQKF-UHFFFAOYSA-N 5-methyl-1H-benzotriazole Chemical compound C1=C(C)C=CC2=NNN=C21 LRUDIIUSNGCQKF-UHFFFAOYSA-N 0.000 description 1
- AOCDQWRMYHJTMY-UHFFFAOYSA-N 5-nitro-2h-benzotriazole Chemical compound C1=C([N+](=O)[O-])C=CC2=NNN=C21 AOCDQWRMYHJTMY-UHFFFAOYSA-N 0.000 description 1
- XPAZGLFMMUODDK-UHFFFAOYSA-N 6-nitro-1h-benzimidazole Chemical compound [O-][N+](=O)C1=CC=C2N=CNC2=C1 XPAZGLFMMUODDK-UHFFFAOYSA-N 0.000 description 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 description 1
- ZOXJGFHDIHLPTG-UHFFFAOYSA-N Boron Chemical compound [B] ZOXJGFHDIHLPTG-UHFFFAOYSA-N 0.000 description 1
- LVDKZNITIUWNER-UHFFFAOYSA-N Bronopol Chemical compound OCC(Br)(CO)[N+]([O-])=O LVDKZNITIUWNER-UHFFFAOYSA-N 0.000 description 1
- OKIJSNGRQAOIGZ-UHFFFAOYSA-N Butopyronoxyl Chemical compound CCCCOC(=O)C1=CC(=O)CC(C)(C)O1 OKIJSNGRQAOIGZ-UHFFFAOYSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- YCKRFDGAMUMZLT-UHFFFAOYSA-N Fluorine atom Chemical compound [F] YCKRFDGAMUMZLT-UHFFFAOYSA-N 0.000 description 1
- VQTUBCCKSQIDNK-UHFFFAOYSA-N Isobutene Chemical group CC(C)=C VQTUBCCKSQIDNK-UHFFFAOYSA-N 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- 150000000996 L-ascorbic acids Chemical class 0.000 description 1
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
- 229920000881 Modified starch Polymers 0.000 description 1
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
- 235000008331 Pinus X rigitaeda Nutrition 0.000 description 1
- 235000011613 Pinus brutia Nutrition 0.000 description 1
- 241000018646 Pinus brutia Species 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- VOLMSPGWNYJHQQ-UHFFFAOYSA-N Pyranone Natural products CC1=C(O)C(=O)C(O)CO1 VOLMSPGWNYJHQQ-UHFFFAOYSA-N 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 229910021607 Silver chloride Inorganic materials 0.000 description 1
- FOIXSVOLVBLSDH-UHFFFAOYSA-N Silver ion Chemical compound [Ag+] FOIXSVOLVBLSDH-UHFFFAOYSA-N 0.000 description 1
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- ULUAUXLGCMPNKK-UHFFFAOYSA-N Sulfobutanedioic acid Chemical compound OC(=O)CC(C(O)=O)S(O)(=O)=O ULUAUXLGCMPNKK-UHFFFAOYSA-N 0.000 description 1
- ZMZDMBWJUHKJPS-UHFFFAOYSA-M Thiocyanate anion Chemical compound [S-]C#N ZMZDMBWJUHKJPS-UHFFFAOYSA-M 0.000 description 1
- OMOVVBIIQSXZSZ-UHFFFAOYSA-N [6-(4-acetyloxy-5,9a-dimethyl-2,7-dioxo-4,5a,6,9-tetrahydro-3h-pyrano[3,4-b]oxepin-5-yl)-5-formyloxy-3-(furan-3-yl)-3a-methyl-7-methylidene-1a,2,3,4,5,6-hexahydroindeno[1,7a-b]oxiren-4-yl] 2-hydroxy-3-methylpentanoate Chemical compound CC12C(OC(=O)C(O)C(C)CC)C(OC=O)C(C3(C)C(CC(=O)OC4(C)COC(=O)CC43)OC(C)=O)C(=C)C32OC3CC1C=1C=COC=1 OMOVVBIIQSXZSZ-UHFFFAOYSA-N 0.000 description 1
- SJOOOZPMQAWAOP-UHFFFAOYSA-N [Ag].BrCl Chemical compound [Ag].BrCl SJOOOZPMQAWAOP-UHFFFAOYSA-N 0.000 description 1
- XCFIVNQHHFZRNR-UHFFFAOYSA-N [Ag].Cl[IH]Br Chemical compound [Ag].Cl[IH]Br XCFIVNQHHFZRNR-UHFFFAOYSA-N 0.000 description 1
- HOLVRJRSWZOAJU-UHFFFAOYSA-N [Ag].ICl Chemical compound [Ag].ICl HOLVRJRSWZOAJU-UHFFFAOYSA-N 0.000 description 1
- FZQSLXQPHPOTHG-UHFFFAOYSA-N [K+].[K+].O1B([O-])OB2OB([O-])OB1O2 Chemical compound [K+].[K+].O1B([O-])OB2OB([O-])OB1O2 FZQSLXQPHPOTHG-UHFFFAOYSA-N 0.000 description 1
- MVCMTOJZXPCZNM-UHFFFAOYSA-I [Na+].[Na+].[Na+].[Na+].[Na+].CC([O-])=O.CC([O-])=O.CC([O-])=O.CC([O-])=O.CC([O-])=O.NCCNCCN Chemical compound [Na+].[Na+].[Na+].[Na+].[Na+].CC([O-])=O.CC([O-])=O.CC([O-])=O.CC([O-])=O.CC([O-])=O.NCCNCCN MVCMTOJZXPCZNM-UHFFFAOYSA-I 0.000 description 1
- SZHJTBRHSAKQIF-UHFFFAOYSA-N [Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].OB(O)O.[O-]B([O-])[O-].[O-]B([O-])[O-].[O-]B([O-])[O-].[O-]B([O-])[O-] Chemical compound [Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].OB(O)O.[O-]B([O-])[O-].[O-]B([O-])[O-].[O-]B([O-])[O-].[O-]B([O-])[O-] SZHJTBRHSAKQIF-UHFFFAOYSA-N 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 150000001242 acetic acid derivatives Chemical class 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 125000004442 acylamino group Chemical group 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000004931 aggregating effect Effects 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- 150000001299 aldehydes Chemical group 0.000 description 1
- 229910001508 alkali metal halide Inorganic materials 0.000 description 1
- 150000008045 alkali metal halides Chemical class 0.000 description 1
- 229910001413 alkali metal ion Inorganic materials 0.000 description 1
- 125000004466 alkoxycarbonylamino group Chemical group 0.000 description 1
- 125000004414 alkyl thio group Chemical group 0.000 description 1
- SOIFLUNRINLCBN-UHFFFAOYSA-N ammonium thiocyanate Chemical compound [NH4+].[S-]C#N SOIFLUNRINLCBN-UHFFFAOYSA-N 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 125000004429 atom Chemical group 0.000 description 1
- JOILQYURMOSQTJ-UHFFFAOYSA-N azanium;2,4-dihydroxybenzenesulfonate Chemical compound [NH4+].OC1=CC=C(S([O-])(=O)=O)C(O)=C1 JOILQYURMOSQTJ-UHFFFAOYSA-N 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- QRUDEWIWKLJBPS-UHFFFAOYSA-N benzotriazole Chemical compound C1=CC=C2N[N][N]C2=C1 QRUDEWIWKLJBPS-UHFFFAOYSA-N 0.000 description 1
- 239000012964 benzotriazole Substances 0.000 description 1
- 229910021538 borax Inorganic materials 0.000 description 1
- 229910052796 boron Inorganic materials 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000004744 butyloxycarbonyl group Chemical group 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 125000006297 carbonyl amino group Chemical group [H]N([*:2])C([*:1])=O 0.000 description 1
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- GTKRFUAGOKINCA-UHFFFAOYSA-M chlorosilver;silver Chemical class [Ag].[Ag]Cl GTKRFUAGOKINCA-UHFFFAOYSA-M 0.000 description 1
- 239000011247 coating layer Substances 0.000 description 1
- 239000008119 colloidal silica Substances 0.000 description 1
- 238000004891 communication Methods 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 229940126214 compound 3 Drugs 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000001143 conditioned effect Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 238000003851 corona treatment Methods 0.000 description 1
- 238000007766 curtain coating Methods 0.000 description 1
- 238000010908 decantation Methods 0.000 description 1
- 238000011033 desalting Methods 0.000 description 1
- VILAVOFMIJHSJA-UHFFFAOYSA-N dicarbon monoxide Chemical group [C]=C=O VILAVOFMIJHSJA-UHFFFAOYSA-N 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 238000003618 dip coating Methods 0.000 description 1
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 description 1
- 235000019797 dipotassium phosphate Nutrition 0.000 description 1
- 229910000396 dipotassium phosphate Inorganic materials 0.000 description 1
- 208000028659 discharge Diseases 0.000 description 1
- RZMWTGFSAMRLQH-UHFFFAOYSA-L disodium;2,2-dihexyl-3-sulfobutanedioate Chemical compound [Na+].[Na+].CCCCCCC(C([O-])=O)(C(C([O-])=O)S(O)(=O)=O)CCCCCC RZMWTGFSAMRLQH-UHFFFAOYSA-L 0.000 description 1
- 239000002612 dispersion medium Substances 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- SAIGUZYNPDJAHY-UHFFFAOYSA-N ethane;2-ethenylsulfonylacetamide Chemical compound CC.NC(=O)CS(=O)(=O)C=C SAIGUZYNPDJAHY-UHFFFAOYSA-N 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 125000000816 ethylene group Chemical group [H]C([H])([*:1])C([H])([H])[*:2] 0.000 description 1
- ALCDAWARCQFJBA-UHFFFAOYSA-N ethylselanylethane Chemical compound CC[Se]CC ALCDAWARCQFJBA-UHFFFAOYSA-N 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 238000001125 extrusion Methods 0.000 description 1
- 238000007765 extrusion coating Methods 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 230000009477 glass transition Effects 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 125000005842 heteroatom Chemical group 0.000 description 1
- 150000002429 hydrazines Chemical class 0.000 description 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 1
- ZMZDMBWJUHKJPS-UHFFFAOYSA-N hydrogen thiocyanate Natural products SC#N ZMZDMBWJUHKJPS-UHFFFAOYSA-N 0.000 description 1
- 150000004679 hydroxides Chemical class 0.000 description 1
- WTNULKDCIHSVKN-UHFFFAOYSA-N imidazo[1,2-a]pyridin-2-ol Chemical compound C1=CC=CC2=NC(O)=CN21 WTNULKDCIHSVKN-UHFFFAOYSA-N 0.000 description 1
- 150000002460 imidazoles Chemical class 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 150000008040 ionic compounds Chemical class 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- FZWBNHMXJMCXLU-BLAUPYHCSA-N isomaltotriose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@@H](OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O)O1 FZWBNHMXJMCXLU-BLAUPYHCSA-N 0.000 description 1
- BITXABIVVURDNX-UHFFFAOYSA-N isoselenocyanic acid Chemical class N=C=[Se] BITXABIVVURDNX-UHFFFAOYSA-N 0.000 description 1
- 239000004816 latex Substances 0.000 description 1
- 229920000126 latex Polymers 0.000 description 1
- 229910052744 lithium Inorganic materials 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000006224 matting agent Substances 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- LVWZTYCIRDMTEY-UHFFFAOYSA-N metamizole Chemical compound O=C1C(N(CS(O)(=O)=O)C)=C(C)N(C)N1C1=CC=CC=C1 LVWZTYCIRDMTEY-UHFFFAOYSA-N 0.000 description 1
- 125000006626 methoxycarbonylamino group Chemical group 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 239000012046 mixed solvent Substances 0.000 description 1
- 235000019426 modified starch Nutrition 0.000 description 1
- SSZIHNPJCQNODF-UHFFFAOYSA-N n,n-dimethylbenzenecarboselenoamide Chemical compound CN(C)C(=[Se])C1=CC=CC=C1 SSZIHNPJCQNODF-UHFFFAOYSA-N 0.000 description 1
- 229910017604 nitric acid Inorganic materials 0.000 description 1
- FYWSTUCDSVYLPV-UHFFFAOYSA-N nitrooxythallium Chemical compound [Tl+].[O-][N+]([O-])=O FYWSTUCDSVYLPV-UHFFFAOYSA-N 0.000 description 1
- TWNQGVIAIRXVLR-UHFFFAOYSA-N oxo(oxoalumanyloxy)alumane Chemical compound O=[Al]O[Al]=O TWNQGVIAIRXVLR-UHFFFAOYSA-N 0.000 description 1
- VGTPKLINSHNZRD-UHFFFAOYSA-N oxoborinic acid Chemical compound OB=O VGTPKLINSHNZRD-UHFFFAOYSA-N 0.000 description 1
- 150000004989 p-phenylenediamines Chemical class 0.000 description 1
- 239000003002 pH adjusting agent Substances 0.000 description 1
- 239000006174 pH buffer Substances 0.000 description 1
- 239000005022 packaging material Substances 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 125000004817 pentamethylene group Chemical group [H]C([H])([*:2])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[*:1] 0.000 description 1
- 125000000843 phenylene group Chemical group C1(=C(C=CC=C1)*)* 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 239000002985 plastic film Substances 0.000 description 1
- 229920006255 plastic film Polymers 0.000 description 1
- 229920000233 poly(alkylene oxides) Polymers 0.000 description 1
- 229920003229 poly(methyl methacrylate) Polymers 0.000 description 1
- 229920001467 poly(styrenesulfonates) Polymers 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 239000004584 polyacrylic acid Substances 0.000 description 1
- 239000004926 polymethyl methacrylate Substances 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 235000019422 polyvinyl alcohol Nutrition 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- FRMWBRPWYBNAFB-UHFFFAOYSA-M potassium salicylate Chemical compound [K+].OC1=CC=CC=C1C([O-])=O FRMWBRPWYBNAFB-UHFFFAOYSA-M 0.000 description 1
- BHZRJJOHZFYXTO-UHFFFAOYSA-L potassium sulfite Chemical compound [K+].[K+].[O-]S([O-])=O BHZRJJOHZFYXTO-UHFFFAOYSA-L 0.000 description 1
- 235000019252 potassium sulphite Nutrition 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000004805 propylene group Chemical group [H]C([H])([H])C([H])([*:1])C([H])([H])[*:2] 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- NDGRWYRVNANFNB-UHFFFAOYSA-N pyrazolidin-3-one Chemical class O=C1CCNN1 NDGRWYRVNANFNB-UHFFFAOYSA-N 0.000 description 1
- 150000003242 quaternary ammonium salts Chemical class 0.000 description 1
- 238000007634 remodeling Methods 0.000 description 1
- 238000007761 roller coating Methods 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 description 1
- IYKVLICPFCEZOF-UHFFFAOYSA-N selenourea Chemical compound NC(N)=[Se] IYKVLICPFCEZOF-UHFFFAOYSA-N 0.000 description 1
- ZUNKMNLKJXRCDM-UHFFFAOYSA-N silver bromoiodide Chemical compound [Ag].IBr ZUNKMNLKJXRCDM-UHFFFAOYSA-N 0.000 description 1
- HKZLPVFGJNLROG-UHFFFAOYSA-M silver monochloride Chemical compound [Cl-].[Ag+] HKZLPVFGJNLROG-UHFFFAOYSA-M 0.000 description 1
- IKTXPEUEHIYXND-UHFFFAOYSA-N silver nitrate hydrate Chemical compound O.[Ag+].[O-][N+]([O-])=O IKTXPEUEHIYXND-UHFFFAOYSA-N 0.000 description 1
- 239000004320 sodium erythorbate Substances 0.000 description 1
- 235000010352 sodium erythorbate Nutrition 0.000 description 1
- 239000000176 sodium gluconate Substances 0.000 description 1
- 235000012207 sodium gluconate Nutrition 0.000 description 1
- 229940005574 sodium gluconate Drugs 0.000 description 1
- 239000001488 sodium phosphate Substances 0.000 description 1
- 229940006186 sodium polystyrene sulfonate Drugs 0.000 description 1
- 229960004025 sodium salicylate Drugs 0.000 description 1
- 229910052979 sodium sulfide Inorganic materials 0.000 description 1
- GRVFOGOEDUUMBP-UHFFFAOYSA-N sodium sulfide (anhydrous) Chemical compound [Na+].[Na+].[S-2] GRVFOGOEDUUMBP-UHFFFAOYSA-N 0.000 description 1
- 235000010339 sodium tetraborate Nutrition 0.000 description 1
- RBWSWDPRDBEWCR-RKJRWTFHSA-N sodium;(2r)-2-[(2r)-3,4-dihydroxy-5-oxo-2h-furan-2-yl]-2-hydroxyethanolate Chemical compound [Na+].[O-]C[C@@H](O)[C@H]1OC(=O)C(O)=C1O RBWSWDPRDBEWCR-RKJRWTFHSA-N 0.000 description 1
- HQPBCGYUKKDAHP-UHFFFAOYSA-M sodium;2-(5-sulfanylidene-2h-tetrazol-1-yl)acetate Chemical compound [Na+].[O-]C(=O)CN1NN=NC1=S HQPBCGYUKKDAHP-UHFFFAOYSA-M 0.000 description 1
- RILRIYCWJQJNTJ-UHFFFAOYSA-M sodium;3-carboxy-4-hydroxybenzenesulfonate Chemical compound [Na+].OC(=O)C1=CC(S([O-])(=O)=O)=CC=C1O RILRIYCWJQJNTJ-UHFFFAOYSA-M 0.000 description 1
- KMQKYDWPAZMUDX-UHFFFAOYSA-M sodium;hydrogen sulfite;pentanedial Chemical compound [Na+].OS([O-])=O.O=CCCCC=O KMQKYDWPAZMUDX-UHFFFAOYSA-M 0.000 description 1
- 239000007962 solid dispersion Substances 0.000 description 1
- 238000001694 spray drying Methods 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 125000001424 substituent group Chemical group 0.000 description 1
- 125000000020 sulfo group Chemical group O=S(=O)([*])O[H] 0.000 description 1
- 239000008400 supply water Substances 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 150000003498 tellurium compounds Chemical class 0.000 description 1
- 150000003568 thioethers Chemical class 0.000 description 1
- 125000003396 thiol group Chemical group [H]S* 0.000 description 1
- 231100000027 toxicology Toxicity 0.000 description 1
- 238000013519 translation Methods 0.000 description 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 description 1
- WUUHFRRPHJEEKV-UHFFFAOYSA-N tripotassium borate Chemical compound [K+].[K+].[K+].[O-]B([O-])[O-] WUUHFRRPHJEEKV-UHFFFAOYSA-N 0.000 description 1
- 235000019798 tripotassium phosphate Nutrition 0.000 description 1
- 229910000404 tripotassium phosphate Inorganic materials 0.000 description 1
- BSVBQGMMJUBVOD-UHFFFAOYSA-N trisodium borate Chemical compound [Na+].[Na+].[Na+].[O-]B([O-])[O-] BSVBQGMMJUBVOD-UHFFFAOYSA-N 0.000 description 1
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 1
- 229910000406 trisodium phosphate Inorganic materials 0.000 description 1
- 235000019801 trisodium phosphate Nutrition 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- 238000003911 water pollution Methods 0.000 description 1
- 229920003169 water-soluble polymer Polymers 0.000 description 1
- 125000006839 xylylene group Chemical group 0.000 description 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
- 229910003156 β-AgI Inorganic materials 0.000 description 1
Landscapes
- Silver Salt Photography Or Processing Solution Therefor (AREA)
Abstract
Description
【0001】[0001]
【発明の属する技術分野】本発明は、ハロゲン化銀写真
感光材料の処理方法に関し、詳しくは自動現像機でハロ
ゲン化銀写真感光材料を処理する際、過酷な処理条件下
でも好適なハロゲン化銀写真感光材料の処理方法に関す
る。BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a method for processing a silver halide photographic light-sensitive material, and more particularly, to a method suitable for processing a silver halide photographic light-sensitive material with an automatic processor even under severe processing conditions. The present invention relates to a method for processing a photographic material.
【0002】[0002]
【従来の技術】ハロゲン化銀写真感光材料のうち、医療
用のX線フィルムとして直医用、間接用、CRT用、レ
ーザーイメジャー用等があるが、いずれも自動現像機に
て現像処理が行われている。各医療用施設によって様々
な使用条件によって自動現像機による処理が行われてお
り、大規模施設による1日当たり400〜500枚処理
する大規模処理から、開業医等の小規模施設による10
枚以下の小規模処理、救急病院による自動現像機の稼働
時間が24時間/日の全日稼働処理など様々である。2. Description of the Related Art Among silver halide photographic materials, X-ray films for medical use include direct medical use, indirect use, CRT use, laser image use, and the like. Have been done. Each medical facility performs processing by an automatic developing machine under various use conditions. From large-scale processing of processing 400 to 500 sheets per day by a large-scale facility to 10-minute processing by a small-scale facility such as a medical practitioner.
There are various types of processing, such as small-scale processing of less than one sheet, and all-day operation of an automatic processor by an emergency hospital for 24 hours / day.
【0003】従って施設毎に種々に自動現像機による処
理条件が異なることから処理液の蒸発により濃縮が進行
したり、処理液成分の結晶が生じたり等して、処理フィ
ルムの性能(センシトメトリー)を大きく変動させ、場
合によっては故障(フィルムへの結晶物付着、膜剥がれ
等)を引き起こしてしまう。通常、3ヶ月に一度液更新
をし、1ヶ月に一度は自動現像機処理槽(現像槽、定着
槽、水洗槽)及び現像処理ラック(現像搬送ラック、定
着搬送ラック、現像−定着ワタリラック、定着−水洗ワ
タリラック、水洗ラック、スクイズラック)を清掃する
ことが推奨されているが、これらを実行しても前記処理
安定性(性能、故障)が不十分な場合があり、より安定
な自動現像機による処理方法が求められていた。[0003] Since the processing conditions of the automatic developing machine differ from facility to facility, concentration of the processing solution proceeds, and crystals of the processing solution components are formed, and the performance (sensitometry) of the processing film is increased. ) Greatly fluctuates, and in some cases, causes a failure (attachment of a crystal to a film, peeling of a film, etc.). Usually, the solution is renewed once every three months, and once a month, the processing tanks of the automatic developing machine (developing tank, fixing tank, washing tank) and the developing processing racks (developing conveyance rack, fixing conveyance rack, development-fixing water rack, It is recommended to clean (fixing-washing water rack, washing rack, squeeze rack), but even if these processes are performed, the processing stability (performance, failure) may be insufficient. There has been a demand for a processing method using a developing machine.
【0004】殊に処理液濃縮化、連続処理が継続する過
酷な処理条件のもとで発生しやすくなる診断上致命的と
なる濃度ムラ、銀スラッジや結晶付着による濃度欠陥の
発生の防止が切望されていた。In particular, it is desired to prevent the occurrence of density unevenness which is likely to occur under severe processing conditions in which the processing solution is concentrated and continuous processing is continued and which is fatal in diagnosis, and density defects due to silver sludge and crystal adhesion. It had been.
【0005】[0005]
【発明が解決しようとする課題】本発明は上記事情に鑑
みてなされたものであり、その目的は、自動現像機でハ
ロゲン化銀写真感光材料を処理する際の、処理液低補充
化、連続処理の長期継続化、処理液疲労濃縮化等の過酷
な処理条件下で発生しやすくなる診断上致命的となる濃
度ムラ、銀スラッジや結晶付着による濃度欠陥の発生が
改善されたハロゲン化銀写真感光材料の処理方法を提供
することにある。SUMMARY OF THE INVENTION The present invention has been made in view of the above circumstances, and has as its object to reduce the replenishment of a processing solution when processing a silver halide photographic light-sensitive material with an automatic developing machine. A silver halide photograph with improved density non-uniformity, which is likely to occur under severe processing conditions such as prolonged processing and concentration of processing solution fatigue, which is fatal for diagnosis, and density defects due to silver sludge and crystal adhesion are improved. An object of the present invention is to provide a method for processing a photosensitive material.
【0006】[0006]
【課題を解決するための手段】本発明の上記目的は、下
記構成により達成される。The above object of the present invention is achieved by the following constitution.
【0007】1.支持体上にハロゲン化銀写真乳剤層と
非感光性親水性コロイド層を有するハロゲン化銀写真感
光材料を、少なくとも現像液、定着液及び水洗水を有す
る自動現像機で処理する処理方法において、該感光材料
が前記一般式(1)または(2)で表される化合物を含
有し、かつ現像液がレダクトン類を含有することを特徴
とするハロゲン化銀写真感光材料の処理方法。[0007] 1. In a processing method, a silver halide photographic light-sensitive material having a silver halide photographic emulsion layer and a non-photosensitive hydrophilic colloid layer on a support is processed by an automatic developing machine having at least a developing solution, a fixing solution and washing water. A method for processing a silver halide photographic light-sensitive material, characterized in that the light-sensitive material contains the compound represented by the general formula (1) or (2) and the developer contains reductones.
【0008】2.支持体上にハロゲン化銀写真乳剤層と
非感光性親水性コロイド層を有するハロゲン化銀写真感
光材料を、少なくとも現像液、定着液及び水洗水を有す
る自動現像機で処理する処理方法において、該感光材料
が前記一般式(1)または(2)で表される化合物を含
有し、かつ現像液及び定着液が実質的にアンモニウム塩
を含有しないことを特徴とするハロゲン化銀写真感光材
料の処理方法。[0008] 2. In a processing method, a silver halide photographic light-sensitive material having a silver halide photographic emulsion layer and a non-photosensitive hydrophilic colloid layer on a support is processed by an automatic developing machine having at least a developing solution, a fixing solution and washing water. Processing of a silver halide photographic light-sensitive material, characterized in that the light-sensitive material contains a compound represented by the above general formula (1) or (2), and the developing solution and the fixing solution contain substantially no ammonium salt. Method.
【0009】3.支持体上にハロゲン化銀写真乳剤層と
非感光性親水性コロイド層を有するハロゲン化銀写真感
光材料を、少なくとも現像液、定着液及び水洗水を有す
る自動現像機で処理する処理方法において、該感光材料
が前記一般式(1)または(2)で表される化合物を含
有し、かつ現像液がグルタルアルデヒド化合物を実質的
に含有せず、かつ定着液がアルミニウムイオンを実質的
に含有しないことを特徴とするハロゲン化銀写真感光材
料の処理方法。3. In a processing method, a silver halide photographic light-sensitive material having a silver halide photographic emulsion layer and a non-photosensitive hydrophilic colloid layer on a support is processed by an automatic developing machine having at least a developing solution, a fixing solution and washing water. The photosensitive material contains the compound represented by the general formula (1) or (2), the developer does not substantially contain a glutaraldehyde compound, and the fixer does not substantially contain aluminum ions. A method for processing a silver halide photographic light-sensitive material, comprising:
【0010】4.支持体上にハロゲン化銀写真乳剤層と
非感光性親水性コロイド層を有するハロゲン化銀写真感
光材料を、少なくとも現像液、定着液及び水洗水を有す
る自動現像機で処理する処理方法において、該感光材料
が前記一般式(1)または(2)で表される化合物を含
有し、かつ現像液及び定着液が実質的にホウ素化合物を
含有しないことを特徴とするハロゲン化銀写真感光材料
の処理方法。[0010] 4. In a processing method, a silver halide photographic light-sensitive material having a silver halide photographic emulsion layer and a non-photosensitive hydrophilic colloid layer on a support is processed by an automatic developing machine having at least a developing solution, a fixing solution and washing water. Processing of a silver halide photographic light-sensitive material, characterized in that the light-sensitive material contains a compound represented by the above general formula (1) or (2), and the developer and the fixer contain substantially no boron compound. Method.
【0011】5.支持体上にハロゲン化銀写真乳剤層と
非感光性親水性コロイド層を有するハロゲン化銀写真感
光材料を、少なくとも現像液、定着液及び水洗水を有す
る自動現像機で処理する処理方法において、該感光材料
が前記一般式(1)または(2)で表される化合物を含
有し、かつ定着液が実質的に酢酸塩を含有せず、亜硫酸
塩を0.5〜1.5mol/L含有することを特徴とす
るハロゲン化銀写真感光材料の処理方法。5. In a processing method, a silver halide photographic light-sensitive material having a silver halide photographic emulsion layer and a non-photosensitive hydrophilic colloid layer on a support is processed by an automatic developing machine having at least a developing solution, a fixing solution and washing water. The light-sensitive material contains the compound represented by the above general formula (1) or (2), and the fixer contains substantially no acetate and contains 0.5 to 1.5 mol / L of sulfite. A method for processing a silver halide photographic material.
【0012】6.支持体上にハロゲン化銀写真乳剤層と
非感光性親水性コロイド層を有するハロゲン化銀写真感
光材料を、少なくとも現像液、定着液及び水洗水を有す
る自動現像機で処理する処理方法において、該感光材料
が前記一般式(1)または(2)で表される化合物を含
有し、該感光材料の現像液処理中及び定着液処理中の膨
潤度が100〜200%であることを特徴とするハロゲ
ン化銀写真感光材料の処理方法。6. In a processing method, a silver halide photographic light-sensitive material having a silver halide photographic emulsion layer and a non-photosensitive hydrophilic colloid layer on a support is processed by an automatic developing machine having at least a developing solution, a fixing solution and washing water. The photosensitive material contains the compound represented by the formula (1) or (2), and the swelling degree of the photosensitive material during processing with a developing solution and processing with a fixing solution is 100 to 200%. A method for processing a silver halide photographic material.
【0013】7.現像液、定着液がそれぞれ固形現像
剤、固形定着剤を溶解したものであることを特徴とする
1〜6のいずれか1項記載のハロゲン化銀写真感光材料
の処理方法。7. 7. The method for processing a silver halide photographic light-sensitive material according to any one of claims 1 to 6, wherein the developer and the fixer are respectively a solid developer and a solid fixer dissolved therein.
【0014】以下、本発明を詳細に説明する。本発明の
一般式(1)および一般式(2)で表される化合物につ
いて説明する。Hereinafter, the present invention will be described in detail. The compounds represented by the general formulas (1) and (2) of the present invention will be described.
【0015】前記一般式(1)に於て、Rfは少なくと
も1つのフッ素原子を含有する脂肪族基を表すが、該脂
肪族基としては炭素数が1〜18であることが好まし
く、2〜12であることがより好ましく、3〜7である
ことが特に好ましい。In the general formula (1), Rf represents an aliphatic group containing at least one fluorine atom, and the aliphatic group preferably has 1 to 18 carbon atoms, It is more preferably 12 and particularly preferably 3 to 7.
【0016】Rf’は少なくとも1つのフッ素原子を含
有するアルキレン基を表すが、その炭素数が1〜8であ
ることが好ましく、2〜5であることがより好ましく、
2または3であることが特に好ましい。Rf 'represents an alkylene group containing at least one fluorine atom, preferably having 1 to 8 carbon atoms, more preferably 2 to 5 carbon atoms,
Particularly preferred is 2 or 3.
【0017】L1は単なる結合手または連結基を表す
が、該連結基としてはアルキレン基、アリーレン基、ヘ
テロ原子を含有した2価の連結基等好ましい。L 1 represents a simple bond or a linking group, and the linking group is preferably an alkylene group, an arylene group, a divalent linking group containing a hetero atom, or the like.
【0018】Xはヒドロキシル基、アニオン性基または
カチオン性基を表すが、アニオン性基としてはカルボキ
シル基、スルホン酸基、リン酸基等が好ましく、カウン
ターカチオンとして、ナトリウムイオン、カリウムイオ
ン等のアルカリ金属イオン、アンモニウムイオン等が好
ましい。カチオン性基としては、4級アルキルアンモニ
ウム基が好ましく、カウンターアニオンとして、ハロゲ
ン化物イオン、p−トルエンスルホン酸イオン等が好ま
しい。X represents a hydroxyl group, an anionic group or a cationic group. The anionic group is preferably a carboxyl group, a sulfonic acid group or a phosphoric acid group, and the counter cation is an alkali ion such as a sodium ion or a potassium ion. Metal ions and ammonium ions are preferred. The cationic group is preferably a quaternary alkylammonium group, and the counter anion is preferably a halide ion, p-toluenesulfonic acid ion or the like.
【0019】n及びmはそれぞれ1以上の整数を表す
が、nが1以上10以下、mが1以上3以下であること
が好ましい。N and m each represent an integer of 1 or more, and it is preferable that n is 1 or more and 10 or less, and m is 1 or more and 3 or less.
【0020】前記一般式(2)に於て、Rf”は炭素原
子を1〜4個有するペルフルオロアルキル基を表すが、
該ペルフルオロアルキル基としてはトリフロロメチル基
が特に好ましい。In the general formula (2), Rf ″ represents a perfluoroalkyl group having 1 to 4 carbon atoms,
As the perfluoroalkyl group, a trifluoromethyl group is particularly preferred.
【0021】(PFC)は、パーフルオロシクロアルキ
レン基を表すが、該パーフルオロシクロアルキレン基と
しては、パーフルオロシクロオクチレン基、パーフルオ
ロシクロヘプチレン基、パーフルオロシクロヘキシレン
基、パーフルオロシクロペンチレン基等が挙げられ、パ
ーフルオロシクロヘキシレン基が特に好ましい。(PFC) represents a perfluorocycloalkylene group, which includes a perfluorocyclooctylene group, a perfluorocycloheptylene group, a perfluorocyclohexylene group, and a perfluorocycloalkylene group. A pentylene group and the like are mentioned, and a perfluorocyclohexylene group is particularly preferred.
【0022】Y1は酸素原子または窒素原子を含有する
連結基を表すが、該連結基としては−OCH2−、−N
HCH2−等が特に好ましい。Y 1 represents a linking group containing an oxygen atom or a nitrogen atom, and the linking groups include —OCH 2 — and —N
HCH 2 — and the like are particularly preferred.
【0023】L2は単なる結合手または連結基を表す
が、該連結基としては置換または未置換のアルキレン基
(例えば、エチレン基、プロピレン基、イソ−ブチレン
基等)、アリレン基(例えば、フェニレン基)、アルキ
レン基とアリレン基の組み合わせ(例えば、キシリレン
基等)、オキシジアルキレン基(例えば、−CH2CH2
OCH2CH2−基等)、チオジアルキレン(例えば、−
CH2CH2SCH2CH2−基)等の多価、一般に二価の
結合基が挙げられる。L 2 represents a simple bond or a linking group, wherein the linking group is a substituted or unsubstituted alkylene group (eg, ethylene group, propylene group, iso-butylene group, etc.), an arylene group (eg, phenylene group) Group), a combination of an alkylene group and an arylene group (eg, a xylylene group), an oxydialkylene group (eg, —CH 2 CH 2)
OCH 2 CH 2 — groups, etc.), thiodialkylenes (eg, —
CH 2 CH 2 SCH 2 CH 2 — group) and the like, and generally a divalent linking group.
【0024】X’はアニオン性基、カチオン性基、ノニ
オン性基または両性基を含む水可溶化極性基を表すが、
アニオン性基としては、−CO2H、−CO2M、−SO
3H、−SO3M、−OSO3H、−OSO3M、−(OC
H2CH2)OSO3M、−OPO(OH)2、−OPO
(OM)2(式中、Mはナトリウム、カリウム、カルシ
ウム等の金属イオンまたはアンモニウムイオンを表す)
等が挙げられ、これらの中でカルボキシル基、スルホン
酸基、リン酸基が好ましく、カウンターカチオンとし
て、ナトリウムイオン、カリウムイオンなどのアルカリ
金属イオン、アンモニウムイオンなどが好ましい。カチ
オン性基としては、4級アルキルアンモニウム基が好ま
しく、カウンターアニオンとして、ハロゲン化物イオ
ン、p−トルエンスルホン酸イオンなどが好ましい。ノ
ニオン性基としてはヒドロキシル基が好ましい。X ′ represents a water-solubilizing polar group containing an anionic group, a cationic group, a nonionic group or an amphoteric group.
Examples of the anionic group, -CO 2 H, -CO 2 M , -SO
3 H, -SO 3 M, -OSO 3 H, -OSO 3 M, - (OC
H 2 CH 2) OSO 3 M , -OPO (OH) 2, -OPO
(OM) 2 (where M represents a metal ion such as sodium, potassium, calcium or the like or an ammonium ion)
Among them, a carboxyl group, a sulfonic acid group, and a phosphoric acid group are preferable, and as the counter cation, an alkali metal ion such as a sodium ion and a potassium ion, and an ammonium ion are preferable. The cationic group is preferably a quaternary alkylammonium group, and the counter anion is preferably a halide ion, p-toluenesulfonic acid ion or the like. As the nonionic group, a hydroxyl group is preferable.
【0025】n1は1〜5の整数を表し、kは1〜3の
整数を表し、m1は1〜5の整数を表すが、n1として
は3が好ましく、kとしては1または2が好ましく、m
1としては1であることが好ましい。N1 represents an integer of 1 to 5, k represents an integer of 1 to 3, and m1 represents an integer of 1 to 5, wherein n1 is preferably 3, and k is preferably 1 or 2, m
It is preferable that 1 is 1.
【0026】以下に、本発明の一般式(1)および一般
式(2)で表される化合物の具体例を示すが、本発明は
これらに限定されるものではない。Hereinafter, specific examples of the compounds represented by the general formulas (1) and (2) of the present invention are shown, but the present invention is not limited thereto.
【0027】一般式(1)表される化合物 1−1.C5F11−(O−CF2)−O−PO(ONa)
2 1−2.HC6F12−(O−CF2)−O−PO(ON
a)2 1−3.C8F17−(O−CF2)−O−PO(ONa)
2 1−4.C10F21−(O−CF2)−O−PO(ON
a)2 1−5.C12F25−(O−CF2)−O−PO(ON
a)2 1−6.C3F7−(O−C2F4)−O−PO(ONa)
2 1−7.C4F9−(O−C2F4)−O−PO(ONa)
2 1−8.C5F11−(O−C2F4)−O−PO(ON
a)2 1−9.HC6F12-(O−C2F4)−O−PO(ON
a)2 1−10.C7F15−(O−C2F4)−O−PO(ON
a)2 1−11.C9F19−(O−C2F4)−O−PO(ON
a)2 1−12.C11F23−(O−C2F4)−O−PO(ON
a)2 1−13.C3F7−(O−CF2)6−O−PO(ON
a)2 1−14.C4F9−(O−CF2)6−O−PO(ON
a)2 1−15.C5F11−(O−CF2)5−O−PO(ON
a)2 1−16.HC6F12−(O−CF2)3−O−PO(O
Na)2 1−17.C3F7−〔O−(CF2)3〕−COONa 1−18.C4F9−〔O−(CF2)3〕−COONa 1−19.C5F11−〔O−(CF2)3〕−COONa 1−20.HC7F14−〔O−(CF2)3〕−O−CH
(COONa)2 1−21.C8F17−〔O−(CF2)3〕−O−CH
(COONa)2 1−22.C3F7−〔O−(CF2)5〕−COONa 1−23.C4F9−〔O−(CF2)5〕−COONa 1−24.C5F11−〔O−(CF2)5〕−COONa 1−25.C7F15−〔O−(CF2)5〕−COONa 1−26.C3F7−(O−C2F4)5−COONa 1−27.C4F9−(O−C2F4)2−COONa 1−28.C5F11−(O−C2F4)2−COONa 1−29.HC7F14−(O−C2F4)2−COONa 1−30.C9F19−(O−C2F4)2−COONa 1−31.C2F5−(O−C2F4)3−COONa 1−32.C2F5−(O−C2F4)5−COONa 1−33.C3F7−(O−C2F4)4−COONa 1−34.C4F9−(O−C2F4)3−COONa 1−35.C5F11−(O−C2F4)3−NHCOCH
(COONa)2 1−36.HC6F12−(O−C2F4)3−NHCOCH
(COONa)2 1−37.C4F9−(O−C2F4)2−OCF2COON
a 1−38.C5F11−(O−C2F4)2−OCF2COO
Na 1−39.C7F15−(O−C2F4)2−OCF2COO
Na 1−40.C4F9−OCF2−〔O−(CF2)5〕−C
OOK 1−41.C5F11−OCF2−〔O−(CF2)5〕−C
OOK 1−42.HC6F12−OCF2−〔O−(CF2)5〕−
COOK 1−43.C4F9−(O−C2F4)5−〔O−(CF2)
3〕−COOK 1−44.C5F11−(O−C2F4)2−〔O−(C
F2)3〕−COOK 1−45.C6F13−(O−C2F4)2−〔O−(C
F2)3〕−COOK 1−46.C12F25−(O−CF2)−O−SO3Na 1−47.C7F15−(O−C2F4)−OC3H6−SO3
Na 1−48.C4F9−(O−CF2)6−O−SO3Na 1−49.HC5F10−(O−CF2)5−OC3H6−S
O3Na 1−50.HC6F12−(O−CF2)3−O−SO3Na 1−51.C5F11−(O−C2F4)2−OC3H6−SO
3Na 1−52.C7F15−(O−C2F4)2−O−SO3Na 1−53.C3F7−(O−C2F4)4−OC3H6−SO3
Na 1−54.C4F9−(O−C2F4)3−O−SO3Na 1−55.HC5F10−(O−C2F4)3−OC3H6−S
O3Na 1−56.C5F11−OCF2−〔O−(CF2)5〕−O
−SO3Na 1−57.C4F9−(O−C2F4)2−〔O−(CF2)
3〕−O−SO3Na 1−58.(HCF2)3C−(O−C2F4)3−O−S
O3Na 1−59.(CF3)2CFCF2CF2−(O−CF2)5
−OC3H6−SO3Na 1−60.C11F23−(O−C2F4)−O−SO3Na 1−61.C4F9−(O−C2F4)3−NHCO−(C
H2)3−N+(CH3)3、Br- 1−62.C5F11−(O−C2F4)2−NHCO−(C
H2)3−N+(CH3) 3、Br- 1−63.HC6F12−(O−C2F4)2−NHCO−
(CH2)3−N+(CH3)3、Br- 1−64.C4F9−(O−C2F4)3−O−CH2−N+
(CH3)2(C2H4OH)、Br- 1−65.C5F11−(O−C2F4)2−O−CH2−N+
(CH3)2(C2H4OH)、Br- 1−66.HC6F12−(O−C2F4)2−O−CH2−
N+(CH3)2(C2H4OH)、Br- 1−67.C5F11−OCF2−(O−C2F4)−NHC
O−(CH2)3−N+(CH3)3、Br- 1−68.(CF3)3C−(O−C2F4)3−O−CH2
−N+(CH3)2(C2H4OH)、Br- 1−69.C12F25−(O−CF2)−OH 1−70.C7F15−(O−C2F4)−OH 1−71.C4F9−(O−CF2)6 −OC3H6−OH 1−72.C5F11−(O−CF2)5−OC3H6−OH 1−73.HC6F12−(O−CF2)3−OH 1−74.C5F11−(O−C2F4)2−OC3H6−OH 1−75.C7F15−(O−C2F4)2−OC3H6−OH 1−76.C3F7−(O−C2F4)4−OC3H6−OH 1−77.HC4F8−(O−C2F4)3−O−C(C2H
4OH)3 1−78.C5F11−(O−C2F4)3−OC3H6−OH 1−79.C5F11−OCF2−〔O−(CF2)5〕−O
H1−80.C4F9−(O−C2F4)2−〔O−(C
F2)3〕−OH 1−81.(CF3)3C−(O−C2F4)3−OH 1−82.(HCF2)2CFCF2CF2−(O−C
F2)5−OH 1−83.C11F23−(O−C2F4)4OH 上記一般式(1)で表される化合物の合成方法について
は、特表平10−500950号、同11−50436
0を参考にすることができる。一般式(2)で表される
化合物 2−1.(CF3O)3(PFC)−CONHC3H6N+
(CH3)2C2H4COO- 2−2.(CF3O)3(PFC)−CONHC3H6N+
(CH3)2C2H4SO3 - 2−3.(CF3O)(PFC)−CONHC3H6N
+(CH3)2C2H4SO3 - 2−4.(CF3O)3(PFC)−CON(C3H6SO
3−)C3H6N+(CH 3)2H 2−5.(CF3O)(PFC)−CON(C3H6SO3
−)C3H6N+(CH3)2H 2−6.[(CF3O)3(PFC)−COOCH2]2C
H−CONHC3H6N +(CH3)2C2H4SO3 - 2−7.[(CF3O)2(PFC)−COOCH2]2C
H−CONHC3H6N +(CH3)2C2H4SO3 - 2−8.[(CF3O)(PFC)−COOCH2]2C
H−CONHC3H6N+(CH3)2C2H4SO3 - 2−9.(CF3O)3(PFC)−CONHC3H6N+
(CH3)2C2H4OH、Cl- 2−10.(CF3O)2(PFC)−CONHC3H6N
+(CH3)2C2H4OH、Cl- 2−11.(CF3O)(PFC)−CONHC3H6N+
(CH3)2C2H4OH、Cl- 2−12.(CF3O)3(PFC)−CONHC3H6N
+(CH3)2H、Cl- 2−13.(CF3O)2(PFC)−CONHC3H6N
+(CH3)2H、Cl- 2−14.(CF3O)(PFC)−CONHC3H6N+
(CH3)2H、Cl- 2−15.[(CF3O)3(PFC)−COOCH2]2
C(CH3)N+(CH 3)2H、Cl- 2−16.[(CF3O)2(PFC)−COOCH2]2
C(CH3)N+(CH 3)2H、Cl- 2−17.[(CF3O)(PFC)−COOCH2]2
C(CH3)N+(CH3)2H、Cl- 2−18.[(CF3O)3(PFC)−COOCH2]2
CHC3H6N+(CH3)2H、Cl- 2−19.[(CF3O)2(PFC)−COOCH2]2
CHC3H6N+(CH3)2H、Cl- 2−20.[(CF3O)(PFC)−COOCH2]2
CHC3H6N+(CH3)2H、Cl- 2−21.(CF3O)3(PFC)−COO(C2H
4O)12H 2−22.(CF3O)2(PFC)−COO(C2H
4O)12H 2−23.(CF3O)(PFC)−COO(C2H
4O)12H 2−24.(CF3O)3(PFC)−COO(C2H
4O)15CH3 2−25.(CF3O)2(PFC)−COO(C2H
4O)15CH3 2−26.(CF3O)(PFC)−COO(C2H
4O)15CH3 2−27.[(CF3O)3(PFC)−COOCH2]2
CHC3H6OH 2−28.[(CF3O)2(PFC)−COOCH2]2
CHC3H6OH 2−29.[(CF3O)(PFC)−COOCH2]2
CHC3H6OH 2−30.(CF3O)3(PFC)−CONHC3H6C
OONa 2−31.(CF3O)2(PFC)−CONHC3H6C
OONa 2−32.(CF3O)(PFC)−CONHC3H6C
OOK 2−33.(CF3O)3(PFC)−CONHC3H6S
O3Na 2−34.(CF3O)2(PFC)−CONHC3H6S
O3Na 2−35.(CF3O)(PFC)−CONHC3H6S
O3K 2−36.(CF3O)3(PFC)−CON(C3H6S
O3Na)C3H7 2−37.(CF3O)2(PFC)−CON(C3H6S
O3Na)C3H7 2−38.(CF3O)(PFC)−CON(C3H6S
O3Na)C3H7 2−39.[(CF3O)3(PFC)−COOCH2]2
C(CH3)COONa 2−40.[(CF3O)2(PFC)−COOCH2]2
C(CH3)COONa 2−41.[(CF3O)(PFC)−COOCH2]2
C(CH3)COONa 2−42.[(CF3O)3(PFC)−COOCH2]2
C(COONa)2 2−43.[(CF3O)2(PFC)−COOCH2]2
C(COONa)2 2−44.[(CF3O)(PFC)−COOCH2]2
C(COONa)2 2−45.[(CF3O)3(PFC)−COOCH2]2
C(CH3)SO3Na 2−46.[(CF3O)2(PFC)−COOCH2]2
C(CH3)SO3Na 2−47.[(CF3O)(PFC)−COOCH2]2
C(CH3)SO3Na 2−48.[(CF3O)3(PFC)−COOCH2]2
CHC3H6SO3Na 2−49.[(CF3O)2(PFC)−COOCH2]2
CHC3H6SO3Na 2−50.[(CF3O)(PFC)−COOCH2]2
CHC3H6SO3Na ただし上記において、(PFC)はパーフルオロシクロ
アルキレン基を表し、(CF3O)の置換位置は、カル
ボニル基を1位として、(CF3O)3の場合は3,4,
5位であり、(CF3O)2の場合は3,4位であり、
(CF3O)の場合は4位である。Compound represented by general formula (1) 1-1. CFiveF11− (O-CFTwo) -O-PO (ONa)
Two 1-2. HC6F12− (O-CFTwo) -O-PO (ON
a)Two 1-3. C8F17− (O-CFTwo) -O-PO (ONa)
Two 1-4. CTenFtwenty one− (O-CFTwo) -O-PO (ON
a)Two 1-5. C12Ftwenty five− (O-CFTwo) -O-PO (ON
a)Two 1-6. CThreeF7− (OCTwoFFour) -O-PO (ONa)
Two 1-7. CFourF9− (OCTwoFFour) -O-PO (ONa)
Two 1-8. CFiveF11− (OCTwoFFour) -O-PO (ON
a)Two 1-9. HC6F12-(OCTwoFFour) -O-PO (ON
a)Two 1-10. C7FFifteen− (OCTwoFFour) -O-PO (ON
a)Two 1-11. C9F19− (OCTwoFFour) -O-PO (ON
a)Two 1-12. C11Ftwenty three− (OCTwoFFour) -O-PO (ON
a)Two 1-13. CThreeF7− (O-CFTwo)6-O-PO (ON
a)Two 1-14. CFourF9− (O-CFTwo)6-O-PO (ON
a)Two 1-15. CFiveF11− (O-CFTwo)Five-O-PO (ON
a)Two 1-16. HC6F12− (O-CFTwo)Three-O-PO (O
Na)Two 1-17. CThreeF7-[O- (CFTwo)Three] -COONa 1-18. CFourF9-[O- (CFTwo)Three] -COONa 1-19. CFiveF11-[O- (CFTwo)Three] -COONa 1-20. HC7F14-[O- (CFTwo)Three] -O-CH
(COONa)Two 1-21. C8F17-[O- (CFTwo)Three] -O-CH
(COONa)Two 1-22. CThreeF7-[O- (CFTwo)Five] -COONa 1-23. CFourF9-[O- (CFTwo)Five] -COONa 1-24. CFiveF11-[O- (CFTwo)Five] -COONa 1-25. C7F15-[O- (CFTwo)Five] -COONa 1-26. CThreeF7− (OCTwoFFour)Five-COONa 1-27. CFourF9− (OCTwoFFour)Two-COONa 1-28. CFiveF11− (OCTwoFFour)Two-COONa 1-29. HC7F14− (OCTwoFFour)Two-COONa 1-30. C9F19− (OCTwoFFour)Two-COONa 1-31. CTwoFFive− (OCTwoFFour)Three-COONa 1-32. CTwoFFive− (OCTwoFFour)Five-COONa 1-33. CThreeF7− (OCTwoFFour)Four-COONa 1-34. CFourF9− (OCTwoFFour)Three-COONa 1-35. CFiveF11− (OCTwoFFour)Three-NHCOCH
(COONa)Two 1-36. HC6F12− (OCTwoFFour)Three-NHCOCH
(COONa)Two 1-37. CFourF9− (OCTwoFFour)Two-OCFTwoCOON
a 1-38. CFiveF11− (OCTwoFFour)Two-OCFTwoCOO
Na 1-39. C7F15− (OCTwoFFour)Two-OCFTwoCOO
Na 1-40. CFourF9-OCFTwo-[O- (CFTwo)Five] -C
OOK 1-41. CFiveF11-OCFTwo-[O- (CFTwo)Five] -C
OOK 1-42. HC6F12-OCFTwo-[O- (CFTwo)Five]-
COOK 1-43. CFourF9− (OCTwoFFour)Five-[O- (CFTwo)
Three] -COOK 1-44. CFiveF11− (OCTwoFFour)Two-[O- (C
FTwo)Three] -COOK 1-45. C6F13− (OCTwoFFour)Two-[O- (C
FTwo)Three] -COOK 1-46. C12Ftwenty five− (O-CFTwo) -O-SOThreeNa 1-47. C7FFifteen− (OCTwoFFour) -OCThreeH6-SOThree
Na 1-48. CFourF9− (O-CFTwo)6-O-SOThreeNa 1-49. HCFiveFTen− (O-CFTwo)Five-OCThreeH6-S
OThreeNa 1-50. HC6F12− (O-CFTwo)Three-O-SOThreeNa 1-51. CFiveF11− (OCTwoFFour)Two-OCThreeH6-SO
ThreeNa 1-52. C7FFifteen− (OCTwoFFour)Two-O-SOThreeNa 1-53. CThreeF7− (OCTwoFFour)Four-OCThreeH6-SOThree
Na 1-54. CFourF9− (OCTwoFFour)Three-O-SOThreeNa 1-55. HCFiveFTen− (OCTwoFFour)Three-OCThreeH6-S
OThreeNa 1-56. CFiveF11-OCFTwo-[O- (CFTwo)Five] -O
-SOThreeNa 1-57. CFourF9− (OCTwoFFour)Two-[O- (CFTwo)
Three] -O-SOThreeNa 1-58. (HCFTwo)ThreeC- (OCTwoFFour)Three-OS
OThreeNa 1-59. (CFThree)TwoCFCFTwoCFTwo− (O-CFTwo)Five
-OCThreeH6-SOThreeNa 1-60. C11Ftwenty three− (OCTwoFFour) -O-SOThreeNa 1-61. CFourF9− (OCTwoFFour)Three-NHCO- (C
HTwo)Three-N+(CHThree)Three, Br- 1-62. CFiveF11− (OCTwoFFour)Two-NHCO- (C
HTwo)Three-N+(CHThree) Three, Br- 1-63. HC6F12− (OCTwoFFour)Two-NHCO-
(CHTwo)Three-N+(CHThree)Three, Br- 1-64. CFourF9− (OCTwoFFour)Three-O-CHTwo-N+
(CHThree)Two(CTwoHFourOH), Br- 1-65. CFiveF11− (OCTwoFFour)Two-O-CHTwo-N+
(CHThree)Two(CTwoHFourOH), Br- 1-66. HC6F12− (OCTwoFFour)Two-O-CHTwo−
N+(CHThree)Two(CTwoHFourOH), Br- 1-67. CFiveF11-OCFTwo− (OCTwoFFour) -NHC
O- (CHTwo)Three-N+(CHThree)Three, Br- 1-68. (CFThree)ThreeC- (OCTwoFFour)Three-O-CHTwo
-N+(CHThree)Two(CTwoHFourOH), Br- 1-69. C12Ftwenty five− (O-CFTwo) -OH 1-70. C7F15− (OCTwoFFour) -OH 1-71. CFourF9− (O-CFTwo)6 -OCThreeH6-OH 1-72. CFiveF11− (O-CFTwo)Five-OCThreeH6-OH 1-73. HC6F12− (O-CFTwo)Three-OH 1-74. CFiveF11− (OCTwoFFour)Two-OCThreeH6-OH 1-75. C7F15− (OCTwoFFour)Two-OCThreeH6-OH 1-76. CThreeF7− (OCTwoFFour)Four-OCThreeH6-OH 1-77. HCFourF8− (OCTwoFFour)Three-OC (CTwoH
FourOH)Three 1-78. CFiveF11− (OCTwoFFour)Three-OCThreeH6-OH 1-79. CFiveF11-OCFTwo-[O- (CFTwo)Five] -O
H1-80. CFourF9− (OCTwoFFour)Two-[O- (C
FTwo)Three] -OH 1-81. (CFThree)ThreeC- (OCTwoFFour)Three-OH 1-82. (HCFTwo)TwoCFCFTwoCFTwo− (OC
FTwo)Five-OH 1-83. C11Ftwenty three− (OCTwoFFour)FourOH About the method of synthesizing the compound represented by the general formula (1)
Is the Japanese translation of Tokuhyo Hei 10-500950 and 11-50436
0 can be referred to. Represented by the general formula (2)
Compound 2-1. (CFThreeO)Three(PFC) -CONHCThreeH6N+
(CHThree)TwoCTwoHFourCOO- 2-2. (CFThreeO)Three(PFC) -CONHCThreeH6N+
(CHThree)TwoCTwoHFourSOThree - 2-3. (CFThreeO) (PFC) -CONHCThreeH6N
+(CHThree)TwoCTwoHFourSOThree - 2-4. (CFThreeO)Three(PFC) -CON (CThreeH6SO
Three−) CThreeH6N+(CH Three)TwoH 2-5. (CFThreeO) (PFC) -CON (CThreeH6SOThree
−) CThreeH6N+(CHThree)TwoH 2-6. [(CFThreeO)Three(PFC) -COOCHTwo]TwoC
H-CONHCThreeH6N +(CHThree)TwoCTwoHFourSOThree - 2-7. [(CFThreeO)Two(PFC) -COOCHTwo]TwoC
H-CONHCThreeH6N +(CHThree)TwoCTwoHFourSOThree - 2-8. [(CFThreeO) (PFC) -COOCHTwo]TwoC
H-CONHCThreeH6N+(CHThree)TwoCTwoHFourSOThree - 2-9. (CFThreeO)Three(PFC) -CONHCThreeH6N+
(CHThree)TwoCTwoHFourOH, Cl- 2-10. (CFThreeO)Two(PFC) -CONHCThreeH6N
+(CHThree)TwoCTwoHFourOH, Cl- 2-11. (CFThreeO) (PFC) -CONHCThreeH6N+
(CHThree)TwoCTwoHFourOH, Cl- 2-12. (CFThreeO)Three(PFC) -CONHCThreeH6N
+(CHThree)TwoH, Cl- 2-13. (CFThreeO)Two(PFC) -CONHCThreeH6N
+(CHThree)TwoH, Cl- 2-14. (CFThreeO) (PFC) -CONHCThreeH6N+
(CHThree)TwoH, Cl- 2-15. [(CFThreeO)Three(PFC) -COOCHTwo]Two
C (CHThree) N+(CH Three)TwoH, Cl- 2-16. [(CFThreeO)Two(PFC) -COOCHTwo]Two
C (CHThree) N+(CH Three)TwoH, Cl- 2-17. [(CFThreeO) (PFC) -COOCHTwo]Two
C (CHThree) N+(CHThree)TwoH, Cl- 2-18. [(CFThreeO)Three(PFC) -COOCHTwo]Two
CHCThreeH6N+(CHThree)TwoH, Cl- 2-19. [(CFThreeO)Two(PFC) -COOCHTwo]Two
CHCThreeH6N+(CHThree)TwoH, Cl- 2-20. [(CFThreeO) (PFC) -COOCHTwo]Two
CHCThreeH6N+(CHThree)TwoH, Cl- 2-21. (CFThreeO)Three(PFC) -COO (CTwoH
FourO)12H 2-22. (CFThreeO)Two(PFC) -COO (CTwoH
FourO)12H 2-23. (CFThreeO) (PFC) -COO (CTwoH
FourO)12H 2-24. (CFThreeO)Three(PFC) -COO (CTwoH
FourO)15CHThree 2-25. (CFThreeO)Two(PFC) -COO (CTwoH
FourO)15CHThree 2-26. (CFThreeO) (PFC) -COO (CTwoH
FourO)15CHThree 2-27. [(CFThreeO)Three(PFC) -COOCHTwo]Two
CHCThreeH6OH 2-28. [(CFThreeO)Two(PFC) -COOCHTwo]Two
CHCThreeH6OH 2-29. [(CFThreeO) (PFC) -COOCHTwo]Two
CHCThreeH6OH 2-30. (CFThreeO)Three(PFC) -CONHCThreeH6C
OONa 2-31. (CFThreeO)Two(PFC) -CONHCThreeH6C
OONa 2-32. (CFThreeO) (PFC) -CONHCThreeH6C
OOK 2-33. (CFThreeO)Three(PFC) -CONHCThreeH6S
OThreeNa 2-34. (CFThreeO)Two(PFC) -CONHCThreeH6S
OThreeNa 2-35. (CFThreeO) (PFC) -CONHCThreeH6S
OThreeK 2-36. (CFThreeO)Three(PFC) -CON (CThreeH6S
OThreeNa) CThreeH7 2-37. (CFThreeO)Two(PFC) -CON (CThreeH6S
OThreeNa) CThreeH7 2-38. (CFThreeO) (PFC) -CON (CThreeH6S
OThreeNa) CThreeH7 2-39. [(CFThreeO)Three(PFC) -COOCHTwo]Two
C (CHThree) COONa 2-40. [(CFThreeO)Two(PFC) -COOCHTwo]Two
C (CHThree) COONa 2-41. [(CFThreeO) (PFC) -COOCHTwo]Two
C (CHThree) COONa 2-42. [(CFThreeO)Three(PFC) -COOCHTwo]Two
C (COONa)Two 2-43. [(CFThreeO)Two(PFC) -COOCHTwo]Two
C (COONa)Two 2-44. [(CFThreeO) (PFC) -COOCHTwo]Two
C (COONa)Two 2-45. [(CFThreeO)Three(PFC) -COOCHTwo]Two
C (CHThree) SOThreeNa 2-46. [(CFThreeO)Two(PFC) -COOCHTwo]Two
C (CHThree) SOThreeNa 2-47. [(CFThreeO) (PFC) -COOCHTwo]Two
C (CHThree) SOThreeNa 2-48. [(CFThreeO)Three(PFC) -COOCHTwo]Two
CHCThreeH6SOThreeNa 2-49. [(CFThreeO)Two(PFC) -COOCHTwo]Two
CHCThreeH6SOThreeNa 2-50. [(CFThreeO) (PFC) -COOCHTwo]Two
CHCThreeH6SOThreeHowever, in the above, (PFC) is a perfluorocyclo
Represents an alkylene group; (CFThreeThe substitution position of O) is
With the carbonyl group as the 1-position, (CFThreeO)ThreeFor 3,4
5th place, (CFThreeO) In the case of 2, it is the third and fourth place,
(CFThreeIn the case of O), it is the fourth place.
【0028】上記一般式(2)で表される化合物の合成
方法については、特開平10−158218号、特表2
000−505803号を参考にすることができる。For the method of synthesizing the compound represented by the general formula (2), see JP-A-10-158218,
000-505803 can be referred to.
【0029】本発明の請求項1記載のレダクトン類とし
ては、下記一般式(3)で表される化合物が好ましく用
いられる。As the reductones according to the first aspect of the present invention, compounds represented by the following general formula (3) are preferably used.
【0030】本発明のレダクトン類は酸化防止剤などの
用途で用いられる場合もあるが、現像主薬として用いら
れることが好ましく本発明の効果がより高く発揮され
る。Although the reductones of the present invention may be used for applications such as antioxidants, they are preferably used as a developing agent, so that the effects of the present invention can be further enhanced.
【0031】[0031]
【化1】 Embedded image
【0032】一般式(3)において、R6及びR7は、各
々ヒドロキシル基、アミノ基(エチル基、ブチル基、ヒ
ドロキシエチル基、炭素数1〜10のアルキル基等で置
換されたものを含む)、アシルアミノ基(アセチルアミ
ノ、ベンゾイルアミノ等)、アルキルスルホニルアミノ
基(メタンスルホニルアミノ等)、アリールスルホニル
アミノ基(ベンゼンスルホニルアミノ、p−トルエンス
ルホニルアミノ等)、アルコキシカルボニルアミノ基
(メトキシカルボニルアミノ等)、メルカプト基又はア
ルキルチオ基(メチルチオ、エチルチオ等)を表す。In the general formula (3), R 6 and R 7 each include those substituted with a hydroxyl group, an amino group (an ethyl group, a butyl group, a hydroxyethyl group, an alkyl group having 1 to 10 carbon atoms, etc.). ), An acylamino group (acetylamino, benzoylamino, etc.), an alkylsulfonylamino group (methanesulfonylamino, etc.), an arylsulfonylamino group (benzenesulfonylamino, p-toluenesulfonylamino, etc.), an alkoxycarbonylamino group (methoxycarbonylamino, etc.) ), A mercapto group or an alkylthio group (methylthio, ethylthio, etc.).
【0033】R6及びR7として好ましい例は、ヒドロキ
シル基、アミノ基、アルキルスルホニルアミノ基及びア
リールスルホニルアミノ基を挙げることができる。Preferred examples of R 6 and R 7 include a hydroxyl group, an amino group, an alkylsulfonylamino group and an arylsulfonylamino group.
【0034】Xは5〜6員環を形成するに必要な原子群
であり、好ましくは炭素原子、酸素原子又は窒素原子か
ら構成され、R6、R7が置換している2つのビニル炭素
原子とカルボニル炭素原子と共同で5〜6員環を構成す
る。X is a group of atoms necessary to form a 5- to 6-membered ring, and is preferably composed of a carbon atom, an oxygen atom or a nitrogen atom, and two vinyl carbon atoms substituted by R 6 and R 7 And a carbonyl carbon atom to form a 5- to 6-membered ring.
【0035】Xの具体例としては、−O−、−C
(R8)(R9)−、−C(R10)=、−C(=O)−、
−N(R11)−、−N=の組合せが挙げられる。ここ
で、R8、R9、R10及びR11は各々、水素原子、炭素数
1〜10の置換してもよいアルキル基(置換基としてヒ
ドロキシル基、カルボキシル基、スルホ基等が挙げられ
る)、ヒドロキシル基又はカルボキシル基を表す。更
に、該5〜6員環は飽和又は不飽和の縮合環を形成して
もよい。Specific examples of X include -O-, -C
(R 8) (R 9) -, - C (R 10) =, - C (= O) -,
—N (R 11 ) — and —N =. Here, each of R 8 , R 9 , R 10 and R 11 is a hydrogen atom, an alkyl group having 1 to 10 carbon atoms which may be substituted (a hydroxyl group, a carboxyl group, a sulfo group, or the like is given as a substituent). , A hydroxyl group or a carboxyl group. Further, the 5- or 6-membered ring may form a saturated or unsaturated condensed ring.
【0036】この5〜6員環の例として、ジヒドロフラ
ノン、ジヒドロピロン、ピラノン、シクロペンテノン、
ピロリノン、ピラゾリノン、ピリドン、アザシクロヘキ
セノン、ウラシル等の各環が挙げられる。好ましい5〜
6員環は、ジヒドロフラノン、シクロペンテノン、シク
ロヘキサノン、ピラゾリノン、アザシクロヘキセノン、
ウラシルの各環である。Examples of the 5- or 6-membered ring include dihydrofuranone, dihydropyrone, pyranone, cyclopentenone,
Each ring includes pyrrolinone, pyrazolinone, pyridone, azacyclohexenone, uracil and the like. Preferred 5
The 6-membered ring includes dihydrofuranone, cyclopentenone, cyclohexanone, pyrazolinone, azacyclohexenone,
Each ring of uracil.
【0037】一般式(3)で表される化合物は、リチウ
ム、ナトリウム、カリウム、アンモニウム等の塩を形成
してもよい。The compound represented by the general formula (3) may form a salt of lithium, sodium, potassium, ammonium and the like.
【0038】以下に一般式(3)で表されるレダクトン
類の具体例を示すが、これらに限定されるものではな
い。Specific examples of the reductone represented by the general formula (3) are shown below, but it should not be construed that the invention is limited thereto.
【0039】[0039]
【化2】 Embedded image
【0040】[0040]
【化3】 Embedded image
【0041】[0041]
【化4】 Embedded image
【0042】上記具体例の中で好ましいのは、アスコル
ビン酸又はエリソルビン酸(立体異性)(3−1)であ
る。上記レダクトン類の使用量は現像液1リットル当た
り1〜100gの範囲でよく、好ましくは5〜50gで
ある。Preferred among the above specific examples is ascorbic acid or erythorbic acid (stereoisomer) (3-1). The amount of the above-mentioned reductones may be in the range of 1 to 100 g, preferably 5 to 50 g per liter of developer.
【0043】本発明において、現像液がジヒドロキシベ
ンゼン化合物を実質的に含有しないことが毒性学の観点
から好ましい。ジヒドロキシベンゼン化合物を実質的に
含まないとは、その含有量が0.001mol/L未満
であることをいう。In the present invention, it is preferable from the viewpoint of toxicology that the developer contains substantially no dihydroxybenzene compound. To be substantially free of a dihydroxybenzene compound means that its content is less than 0.001 mol / L.
【0044】本発明の請求項2記載の現像液および定着
液が実質的にアンモニウム塩を含有しないとは、アンモ
ニウム塩の含有量が0.001mol/L未満であるこ
とを指す。好ましくは全く含有しないことである。現像
液に用いられるアンモニウム塩としては現像促進剤など
が挙げられ、定着液に用いられるアンモニウム塩として
は定着主薬として用いられるチオ硫酸アンモニウム塩等
が挙げられる。The fact that the developer and the fixer according to the second aspect of the present invention do not substantially contain an ammonium salt means that the content of the ammonium salt is less than 0.001 mol / L. Preferably, it is not contained at all. Examples of the ammonium salt used in the developer include a development accelerator, and examples of the ammonium salt used in the fixer include ammonium thiosulfate used as a fixing agent.
【0045】本発明の請求項3記載の現像液がグルタル
アルデヒド化合物を実質的に含有しないとは、その含有
量が0.005mol/L未満であることを指し、本発
明の効果にとっては全く含有しないことが好ましい。グ
ルタルアルデヒドは現像液中にてグルタルアルデヒドそ
のものと、2つのアルデヒド部分のどちらか一方に亜硫
酸が一つ付加したモノ付加体、両方に付加したジ付加
体、脱水した縮合体などいろいろな形態をとるがこれら
の化合物を総称してグルタルアルデヒド化合物と呼び、
含有量はその合計量を指す。The fact that the developer according to the third aspect of the present invention does not substantially contain a glutaraldehyde compound means that the content is less than 0.005 mol / L, and that the developer does not contain any at all for the effect of the present invention. Preferably not. Glutaraldehyde takes various forms in the developer, such as glutaraldehyde itself, a monoadduct in which one of two aldehyde moieties is added with one sulfite, a diadduct in which both are added, and a dehydrated condensate. Collectively refers to these compounds as glutaraldehyde compounds,
Content refers to the total amount.
【0046】また、定着液がアルミニウムイオンを実質
的に含有しないとは、その含有量が0.0001mol
/L未満であることを指し、本発明の効果にとっては全
く含有しないことが好ましい。アルミニウムイオンは定
着液中で数種の水酸化物錯体、酢酸錯体、クエン酸、酒
石酸等のキレート剤の錯体などいろんな形状を取り、本
発明ではこれら全てを総称してアルミニウムイオンと呼
び、含有量はその合計量を指す。Further, the term "fixer does not substantially contain aluminum ions" means that the content is 0.0001 mol.
/ L, and preferably do not contain any at all for the effects of the present invention. Aluminum ions take various forms in the fixing solution, such as several kinds of hydroxide complexes, acetate complexes, citric acid, and complexes of chelating agents such as tartaric acid. In the present invention, these are all collectively referred to as aluminum ions, Indicates the total amount.
【0047】請求項4記載の現像液および定着液が実質
的にホウ素化合物を含有しないとは、その含有量が0.
0001mol/l未満であることを指す。ホウ素化合
物とはホウ酸、メタホウ酸等ホウ素を含む化合物を総称
して言う。In the case where the developing solution and the fixing solution according to the fourth aspect do not substantially contain a boron compound, the content of the developing solution and the fixing solution is preferably 0.1 to 0.1.
0001 mol / l. The boron compound is a generic term for compounds containing boron, such as boric acid and metaboric acid.
【0048】請求項5記載の定着液が実質的に酢酸塩を
含有しないとは、その含有量が0.001mol/l未
満であることを指す。亜硫酸塩の含有量としては0.5
〜1.5mol/lであるが、好ましくは0.6〜1.
2mol/lであり本発明の効果をより高く発揮でき
る。亜硫酸塩とは亜硫酸ソーダ、亜硫酸カリウム等の塩
類を指す。The fact that the fixing solution according to claim 5 does not substantially contain an acetate means that the content is less than 0.001 mol / l. The content of sulfite is 0.5
To 1.5 mol / l, preferably 0.6 to 1.
It is 2 mol / l, so that the effects of the present invention can be further enhanced. Sulfite refers to salts such as sodium sulfite and potassium sulfite.
【0049】請求項6記載の現像液処理中及び定着液処
理中の膨潤度とは、本発明の感光材料が自動現像機で搬
送され現像液に浸りはじめて5秒後から現像液を出るま
での時間の間での平均膨潤度、定着液に浸りはじめて4
秒後から定着液を出るまでの時間の間での平均膨潤度を
指す。The degree of swelling during the processing of the developing solution and the processing of the fixing solution according to the sixth aspect is defined as the value obtained from 5 seconds after the photosensitive material of the present invention is conveyed by an automatic developing machine and begins to be immersed in the developing solution, until the developing solution exits. Average degree of swelling over time, 4
It indicates the average degree of swelling between the time after the second and the time until it leaves the fixing solution.
【0050】膨潤度とは乾燥膜厚(a)、膨潤膜層厚
(b)としたとき、{(b)−(a)}の値を(a)で
除して100倍した値(%)である。膨潤度は100〜
200%であるが、好ましくは100〜160%である
ことが本発明の効果の発揮という観点から好ましい。The degree of swelling is a value obtained by dividing the value of {(b)-(a)} by (a) and multiplying the value by 100 when the dry film thickness (a) and the swelling film layer thickness (b) (%). ). Swelling degree is 100 ~
It is 200%, preferably 100-160%, from the viewpoint of exhibiting the effects of the present invention.
【0051】本発明の感光材料には親水性ポリマーを含
んでよく、含有量として感光材料片面当たり3.5g/
m2以下が好ましく、膜物性その他の観点から1.0g
/m2以上が好ましい。The light-sensitive material of the present invention may contain a hydrophilic polymer, and the content thereof is 3.5 g / side of the light-sensitive material.
m 2 or less, preferably 1.0 g from the viewpoint of film physical properties and other factors.
/ M 2 or more.
【0052】本発明の感光材料のハロゲン化銀乳剤層、
非感光性親水性コロイド層等に用いられる親水性ポリマ
ーの一つはゼラチンである。その他の親水性ポリマーは
特に限定しないが、デキストラン、デキストリン、その
他の多糖類、ポリアクリル酸類などをブレンドすること
ができ、その場合、平均分子量1000〜100万のも
のを用いることが好ましい。中でも、1万〜10万のデ
キストランを用いることが好ましい。ゼラチンと他の親
水性ポリマーをブレンドする場合は、ゼラチンに対し1
〜50質量%が好ましく、更に5〜20質量%が好まし
い。A silver halide emulsion layer of the light-sensitive material of the present invention,
One of the hydrophilic polymers used for the non-photosensitive hydrophilic colloid layer and the like is gelatin. Although other hydrophilic polymers are not particularly limited, dextran, dextrin, other polysaccharides, polyacrylic acids, and the like can be blended. In this case, those having an average molecular weight of 1,000 to 1,000,000 are preferably used. Especially, it is preferable to use 10,000 to 100,000 dextran. When blending gelatin and another hydrophilic polymer, 1
It is preferably from 50 to 50% by mass, more preferably from 5 to 20% by mass.
【0053】上記ゼラチンとしては、石灰処理、酸処理
又は酵素処理したものが好ましく用いられる。又、アセ
チル化ゼラチン、フタル化ゼラチン、メチルエステル化
ゼラチン、プロピルエステル化ゼラチンのようなゼラチ
ン誘導体も用いることができる。As the above gelatin, lime-treated, acid-treated or enzyme-treated gelatin is preferably used. Further, gelatin derivatives such as acetylated gelatin, phthalated gelatin, methyl esterified gelatin, and propyl esterified gelatin can also be used.
【0054】ゼラチン以外の親水性ポリマーの中でも水
溶性ポリマーが好ましく、澱粉誘導体、ポリビニルアル
コール、ポリビニルピロリドン、ポリアクリル酸及びナ
トリウム塩、ポリアクリルアミド、デキストリン、デキ
ストラン、シクロデキストリン、カラギーナン等を挙げ
ることができる。Among hydrophilic polymers other than gelatin, water-soluble polymers are preferable, and examples thereof include starch derivatives, polyvinyl alcohol, polyvinylpyrrolidone, polyacrylic acid and sodium salt, polyacrylamide, dextrin, dextran, cyclodextrin, and carrageenan. .
【0055】本発明の感光材料に用いるハロゲン化銀粒
子としては、特に制限はないが、平板状ハロゲン化銀粒
子でアスペクト比が3以上のものが好ましい。更に好ま
しくは3以上15未満であり、3以上8未満が特に好ま
しい。尚、アスペクト比とは、ハロゲン化銀粒子の投影
面積と同一の面積を有する円の直径と二つの平行な主平
面の距離(厚さ)との比を表す。The silver halide grains used in the light-sensitive material of the present invention are not particularly limited, but tabular silver halide grains having an aspect ratio of 3 or more are preferred. It is more preferably 3 or more and less than 15, and particularly preferably 3 or more and less than 8. The aspect ratio represents the ratio of the diameter of a circle having the same area as the projected area of a silver halide grain to the distance (thickness) between two parallel main planes.
【0056】平板状ハロゲン化銀粒子は、例えば米国特
許5,320,938号記載の方法で調製することがで
きる。即ち、(100)面を形成し易い条件下で、沃度
イオンの存在下、低pClで核形成させることが好まし
い。核形成後は、オストワルド熟成及び/又は成長を行
い、所望の粒径、分布を有する平板状ハロゲン化銀粒子
を得ることができる。平板状ハロゲン化銀粒子は、所謂
ハロゲン変換型(コンバージョン型)の粒子であっても
構わない。ハロゲン変換量は、銀量に対して0.2〜
0.5モル%が好ましく、変換の時期は物理熟成中でも
物理熟成終了後でもよい。Tabular silver halide grains can be prepared, for example, by the method described in US Pat. No. 5,320,938. That is, it is preferable to form nuclei with low pCl in the presence of iodine ions under conditions that facilitate formation of the (100) plane. After nucleation, Ostwald ripening and / or growth is performed to obtain tabular silver halide grains having a desired grain size and distribution. The tabular silver halide grains may be so-called halogen conversion type (conversion type) grains. The halogen conversion amount is 0.2 to
It is preferably 0.5 mol%, and the conversion may be performed during physical ripening or after physical ripening.
【0057】ハロゲン化銀粒子としては、臭化銀、塩化
銀、沃臭化銀、塩臭化銀、沃塩化銀、塩沃臭化銀等を用
いることができる。沃化銀の含有率は、ハロゲン化銀粒
子全体での平均沃化銀含有率として2.0モル%以下が
好ましいが、1.0モル%以下が更に好ましい。As silver halide grains, silver bromide, silver chloride, silver iodobromide, silver chlorobromide, silver iodochloride, silver chloroiodobromide and the like can be used. The silver iodide content is preferably 2.0 mol% or less, more preferably 1.0 mol% or less, as the average silver iodide content of the whole silver halide grains.
【0058】ハロゲン化銀粒子の保護コロイド用分散媒
としてはゼラチンを用いることが好ましく、ゼラチンと
してはアルカリ処理ゼラチン、酸処理ゼラチン、低分子
量ゼラチン(分子量が2万〜10万)、フタル化ゼラチ
ン等の修飾ゼラチンが用いられる。又、これ以外の親水
性コロイドも使用できる。具体的にはリサーチ・ディス
クロージャ誌(Research Disclosur
e、以下RDと略す)176巻,17643,IX項(1
978年12月)に記載されるものが挙げられる。ゼラ
チン量としては、感光材料片面当たりの全親水性コロイ
ド層のゼラチン総量が1.0〜3.5g/m2であるこ
とが好ましい。Gelatin is preferably used as a dispersion medium for the protective colloid of silver halide grains. Examples of the gelatin include alkali-treated gelatin, acid-treated gelatin, low molecular weight gelatin (molecular weight of 20,000 to 100,000), phthalated gelatin and the like. Is used. Other hydrophilic colloids can also be used. Specifically, Research Disclosure Magazine (Research Disclosur)
e, hereinafter abbreviated as RD) 176, 17643, IX (1
978 (Dec. 978). As for the amount of gelatin, the total amount of gelatin in all the hydrophilic colloid layers per one surface of the light-sensitive material is preferably 1.0 to 3.5 g / m 2 .
【0059】ハロゲン化銀粒子の成長時に不要な可溶性
塩類を除去してもよいし、あるいは含有させたままでも
よい。該塩類を除去する場合には、RD176巻,17
643のII項に記載の方法に基づいて行うことができ
る。Unnecessary soluble salts may be removed during the growth of silver halide grains, or they may be kept contained. When the salts are removed, RD 176, 17
It can be carried out based on the method described in 643, section II.
【0060】ハロゲン化銀粒子は化学増感を施すことが
できる。化学熟成即ち化学増感の工程の条件、例えばp
H、pAg、温度、時間等については特に制限がなく、
当業界で一般に行われている条件で行うことができる。
化学増感のためには銀イオンと反応し得る硫黄を含む化
合物や活性ゼラチンを用いる硫黄増感法、セレン化合物
を用いるセレン増感法、テルル化合物を用いるテルル増
感法、還元性物質を用いる還元増感法、金その他、貴金
属を用いる貴金属増感法等を単独又は組み合わせて用い
ることができるが、中でも、セレン増感法、テルル増感
法、還元増感法等が好ましく用いられ、特にセレン増感
法が好ましく用いられる。The silver halide grains can be subjected to chemical sensitization. The conditions of the process of chemical ripening or chemical sensitization, for example, p
There are no particular restrictions on H, pAg, temperature, time, etc.
It can be performed under conditions generally performed in the art.
For chemical sensitization, use a sulfur-containing compound that can react with silver ions or active gelatin, a sulfur sensitization method using a selenium compound, a selenium sensitization method using a selenium compound, a tellurium sensitization method using a tellurium compound, or a reducing substance. Reduction sensitization, gold and other, noble metal sensitization using a noble metal and the like can be used alone or in combination, among which selenium sensitization, tellurium sensitization, reduction sensitization, etc. are preferably used, and in particular, Selenium sensitization is preferably used.
【0061】セレン増感剤に関しては、米国特許1,5
74,944号、同1,602,592号、同1,62
3,499号、特開昭60−150046号、特開平4
−25832号、同4−109240号、同4−147
250号等に記載されている。Regarding the selenium sensitizer, US Pat.
74,944, 1,602,592, 1,62
3,499, JP-A-60-150046, JP-A-4
-25832, 4-109240, 4-147
No. 250, etc.
【0062】有用なセレン増感剤としては、コロイドセ
レン金属、イソセレノシアナート類(アリルイソセレノ
シアナート等)、セレノ尿素類(N,N−ジメチルセレ
ノ尿素、N,N,N′−トリエチルセレノ尿素等)、セ
レノケトン類(セレノアセトン、セレノアセトフェノン
等)、セレノアミド類(セレノアセトアミド、N,N−
ジメチルセレノベンズアミド等)、セレノカルボン酸類
及びセレノエステル類(2−セレノプロピオン酸、メチ
ル−3−セレノブチレート等)、セレノホスフェート類
(トリ−p−トリセレノホスフェート等)、セレナイド
類(ジエチルセレナイド、ジエチルジセレナイド、トリ
フェニルホスフィンセレナイド等)が挙げられる。特に
好ましいセレン増感剤はセレナイド類である。Useful selenium sensitizers include colloidal selenium metal, isoselenocyanates (such as allyl isoselenocyanate), and selenoureas (N, N-dimethylselenourea, N, N, N'-triethyl). Selenourea), selenoketones (selenoacetone, selenoacetophenone, etc.), selenoamides (selenoacetamide, N, N-
Dimethylselenobenzamide, etc.), selenocarboxylic acids and selenoesters (2-selenopropionic acid, methyl-3-selenobutyrate, etc.), selenophosphates (tri-p-triselenophosphate, etc.), selenides (diethylselenide) , Diethyl diselenide, triphenylphosphine selenide, etc.). Particularly preferred selenium sensitizers are selenides.
【0063】セレン増感剤の使用量は、使用するセレン
化合物、ハロゲン化銀粒子、化学熟成条件等により変わ
るが、一般にハロゲン化銀1モル当たり10-8〜10-4
モル程度を用いる。又、添加方法は、使用するセレン化
合物の性質に応じて、水又はメタノール、エタノール、
酢酸エチル等の有機溶媒の単独又は混合溶媒に溶解して
添加する方法でも、あるいは、ゼラチン溶液と予め混合
して添加する方法でも、特開平4−140739号に開
示されている方法、即ち、有機溶媒可溶性の重合体との
混合溶液の乳化分散物の形態で添加する方法でもよい。The amount of the selenium sensitizer used depends on the selenium compound used, silver halide grains, chemical ripening conditions and the like, but is generally from 10 -8 to 10 -4 per mol of silver halide.
Use about moles. The method of addition depends on the nature of the selenium compound used, such as water or methanol, ethanol,
The method disclosed in Japanese Patent Application Laid-Open No. 4-140739, namely, a method in which the organic solvent such as ethyl acetate is dissolved alone or in a mixed solvent, or a method in which the organic solvent is previously mixed with a gelatin solution and added, is used. A method of adding in the form of an emulsified dispersion of a mixed solution with a solvent-soluble polymer may be used.
【0064】ハロゲン化銀乳剤は、シアニン色素類その
他によって分光増感されてもよい。増感色素は単独に用
いてもよいが、それらの組合せを用いてもよく、増感色
素の組合せは特に強色増感の目的でしばしば用いられ
る。The silver halide emulsion may be spectrally sensitized with a cyanine dye or the like. The sensitizing dye may be used alone, or a combination thereof may be used, and the combination of sensitizing dyes is often used particularly for supersensitization.
【0065】本発明の感光材料を医療用両面乳剤X線感
光材料として利用する場合は、画像鮮鋭性を向上させる
目的で横断光遮断層を設けることが好ましい。該横断光
遮断層には、横断光を吸収する目的で染料の固体微粒子
分散体が含有される。このような染料としては、例えば
pH9以上のアルカリには可溶で、pH7以下では難溶
な構造を有する染料であれば特に制限はないが、現像処
理時の脱色性が良いことから特開平6−30870号に
記載の一般式(I)の化合物が好ましく用いられる。X
線用感光材料として利用する場合は、Xレイを露光する
際に、蛍光増感紙として通常用いられるものを使用する
ことができる。When the light-sensitive material of the present invention is used as a medical double-sided emulsion X-ray light-sensitive material, it is preferable to provide a transverse light blocking layer for the purpose of improving image sharpness. The transverse light blocking layer contains a solid fine particle dispersion of a dye for the purpose of absorbing transverse light. Such a dye is not particularly limited as long as it has a structure which is soluble in an alkali having a pH of 9 or more and has a structure which is hardly soluble at a pH of 7 or less. The compound of the general formula (I) described in JP-A-30870 is preferably used. X
When used as a line light-sensitive material, a material commonly used as a fluorescent intensifying screen when exposing X-rays can be used.
【0066】感光材料には、ハロゲン化銀乳剤の物理熟
成又は化学熟成前後の工程で、各種の写真用添加剤を用
いることができる。Various photographic additives can be used in the photographic material before and after physical ripening or chemical ripening of the silver halide emulsion.
【0067】このような工程で使用できる化合物として
は、例えばRD17643号(前出)、RD18716
号(1979年11月)及びRD308119号(19
89年12月)に記載される各種の化合物が挙げられ
る。Compounds that can be used in such a step include, for example, RD17643 (supra), RD18716
No. (November 1979) and RD308119 (19
(December 1989).
【0068】本発明の感光材料に用いられる支持体とし
ては、上記RDに記載されるものが挙げられるが、適当
な支持体としてはプラスチックフィルム等で、支持体表
面は塗布層の接着性を良くするために下引層を設けた
り、コロナ放電や紫外線照射などが施されてもよい。そ
して、このように処理された支持体上の両面にハロゲン
化銀乳剤を塗布することができる。As the support used in the light-sensitive material of the present invention, those described in the above RD can be mentioned. A suitable support is a plastic film or the like, and the surface of the support has good adhesion of the coating layer. For this purpose, an undercoat layer may be provided, or corona discharge or ultraviolet irradiation may be applied. Then, a silver halide emulsion can be coated on both surfaces of the support thus treated.
【0069】感光材料には、その他、必要に応じてアン
チハレーション層、中間層、フィルター層などを設ける
ことができる。The photosensitive material may be provided with an antihalation layer, an intermediate layer, a filter layer and the like, if necessary.
【0070】感光材料のハロゲン化銀乳剤層その他の親
水性コロイド層は、種々の塗布法により支持体上又は他
の層上に塗布できる。塗布には、ディップ塗布法、ロー
ラー塗布法、カーテン塗布法、押出し塗布法、スライド
・ホッパー法などを用いることができる。詳しくは、前
記RD176巻,27〜28頁の「Coatingpr
ocedures」の項に記載される方法を用い得る。The silver halide emulsion layer and other hydrophilic colloid layers of the light-sensitive material can be coated on a support or other layers by various coating methods. For the coating, a dip coating method, a roller coating method, a curtain coating method, an extrusion coating method, a slide hopper method and the like can be used. For details, see "Coatingpr" in RD 176, pp. 27-28.
methods may be used.
【0071】又、感光材料を塗布後、乾燥する時の乾燥
条件は、乾燥時間が1〜5分、含水率1000%以下の
湿球温度が15〜30℃が好ましい。The drying conditions when the photosensitive material is coated and dried are preferably a drying time of 1 to 5 minutes and a wet bulb temperature of not more than 1000% and a wet bulb temperature of 15 to 30 ° C.
【0072】本発明の感光材料の処理方法は、全処理時
間が15〜60秒、より好ましくは15〜30秒である
自動現像機による迅速現像処理において、優れた性能を
示す。The processing method for a light-sensitive material of the present invention exhibits excellent performance in rapid development processing by an automatic processor in which the total processing time is 15 to 60 seconds, more preferably 15 to 30 seconds.
【0073】現像処理における現像剤としては、通常、
白黒写真用である例えばレダクトン類(エリソルビン酸
等)、ジヒドロキシベンゼン類、3−ピラゾリドン類
(1−フェニル−3−ピラゾリドン等)、アミノフェノ
ール類(N−メチル−アミノフェノール等)等を単独又
は併用して用いることができる。請求項1記載の発明で
はレダクトン類が用いられ本発明の効果が発揮される
が、他の請求項記載の発明についてもレダクトン類を含
むことが好ましく、ジヒドロキシベンゼン類を実質的に
含まないことが好ましい。As the developer in the developing process, usually,
For black and white photography, for example, reductones (such as erythorbic acid), dihydroxybenzenes, 3-pyrazolidones (such as 1-phenyl-3-pyrazolidone), and aminophenols (such as N-methyl-aminophenol) alone or in combination Can be used. In the invention of claim 1, reductones are used, and the effect of the present invention is exhibited. However, it is preferable that the inventions of other claims also contain reductones, and that the invention does not substantially contain dihydroxybenzenes. preferable.
【0074】現像液には、保恒剤として特開平6−13
8591号に記載の亜硫酸塩の他、有機還元剤を用いる
ことができ、その他特開平6−138591号に記載の
キレート剤や硬膜剤の重亜硫酸塩付加物を用いることが
できる。又、特開平5−289255号、同6−308
650号に記載の銀スラッジ防止剤、特開平1−124
853号に記載のシクロデキストリン化合物、米国特許
4,269,929号に記載のアミン化合物を添加する
のも好ましい。In the developer, JP-A-6-13 was used as a preservative.
In addition to the sulfite described in No. 8591, an organic reducing agent can be used. In addition, a bisulfite adduct of a chelating agent or a hardener described in JP-A-6-13891 can be used. Also, JP-A-5-289255, JP-A-6-308
No. 650, described in JP-A-1-124.
It is also preferable to add a cyclodextrin compound described in No. 853 and an amine compound described in US Pat. No. 4,269,929.
【0075】又、現像液には緩衝剤を用いることが必要
で、炭酸ナトリウム、炭酸カリウム、重炭酸ナトリウ
ム、重炭酸カリウム、燐酸3ナトリウム、燐酸3カリウ
ム、燐酸2カリウム、硼酸ナトリウム、硼酸カリウム、
4硼酸ナトリウム(硼酸)、4硼酸カリウム、o−ヒド
ロキシ安息香酸ナトリウム(サリチル酸ナトリウム)、
o−ヒドロキシ安息香酸カリウム、5−スルホ−2−ヒ
ドロキシ安息香酸ナトリウム(5−スルホサリチル酸ナ
トリウム)、5−スルホ−2−ヒドロキシ安息香酸カリ
ウム(5−スルホサリチル酸カリウム)等を挙げること
ができ、本発明の構成に応じて必要な緩衝剤を選択でき
る。Further, it is necessary to use a buffer in the developing solution. Sodium carbonate, potassium carbonate, sodium bicarbonate, potassium bicarbonate, trisodium phosphate, tripotassium phosphate, dipotassium phosphate, sodium borate, potassium borate,
Sodium tetraborate (boric acid), potassium tetraborate, sodium o-hydroxybenzoate (sodium salicylate),
Potassium o-hydroxybenzoate, sodium 5-sulfo-2-hydroxybenzoate (sodium 5-sulfosalicylate), potassium 5-sulfo-2-hydroxybenzoate (potassium 5-sulfosalicylate) and the like can be mentioned. The necessary buffer can be selected according to the configuration of the invention.
【0076】更に現像促進剤として、チオエーテル系化
合物、p−フェニレンジアミン系化合物、4級アンモニ
ウム塩類、p−アミノフェノール類、アミン系化合物、
ポリアルキレンオキシド、その他1−フェニル−3−ピ
ラゾリドン類、ヒドラジン類、メソイオン型化合物、イ
オン型化合物、イミダゾール類等を必要に応じて用いる
ことができる。又、カブリ防止剤として、沃化カリウム
の如きアルカリ金属ハロゲン化物及びベンゾトリアゾー
ル、6−ニトロベンゾイミダゾール、5−ニトロイソイ
ンダゾール、5−メチルベンゾトリアゾール、5−ニト
ロベンゾトリアゾール、5−クロロ−ベンゾトリアゾー
ル、2−チアゾリル−ベンゾイミダゾール、2−チアゾ
リルメチル−ベンゾイミダゾール、インダゾール、ヒド
ロキシアザインドリジン、アデニン等の有機カブリ防止
剤が使用できる。Further, thioether compounds, p-phenylenediamine compounds, quaternary ammonium salts, p-aminophenols, amine compounds,
Polyalkylene oxide, other 1-phenyl-3-pyrazolidones, hydrazines, mesoionic compounds, ionic compounds, imidazoles and the like can be used as necessary. As antifoggants, alkali metal halides such as potassium iodide, benzotriazole, 6-nitrobenzimidazole, 5-nitroisoindazole, 5-methylbenzotriazole, 5-nitrobenzotriazole, 5-chloro-benzotriazole , 2-thiazolyl-benzimidazole, 2-thiazolylmethyl-benzimidazole, indazole, hydroxyazaindolizine, adenine and the like organic antifoggants can be used.
【0077】現像液には、更にメチルセロソルブ、メタ
ノール、アセトン、ジメチルホルムアミド、シクロデキ
ストリン化合物、特公昭47−33378号、同44−
9509号に記載の化合物を現像主薬の溶解度を上げる
ための有機溶剤として使用することができ、その他ステ
イン防止剤、銀スラッジ防止剤、重層効果促進剤も用い
ることができる。The developer further includes methyl cellosolve, methanol, acetone, dimethylformamide, a cyclodextrin compound, JP-B-47-33378 and JP-B-44-378.
The compound described in No. 9509 can be used as an organic solvent for increasing the solubility of the developing agent. In addition, a stain inhibitor, a silver sludge inhibitor, and a multilayer effect promoter can also be used.
【0078】定着液には定着主薬やキレート剤、pH緩
衝剤、保恒剤等公知の化合物を用いることができ、例え
ば特開平4−242246号あるいは同5−11363
2号に記載のものが使用できる。Known compounds such as a fixing agent, a chelating agent, a pH buffer and a preservative can be used in the fixing solution. For example, JP-A-4-242246 or JP-A-5-11363 can be used.
No. 2 can be used.
【0079】定着剤としてはチオ硫酸塩、チオシアン酸
塩等が用いられ、更に保恒剤、pH調整剤、硬水軟化剤
等を含んでいてもよい。As the fixing agent, thiosulfate, thiocyanate and the like are used, and may further contain a preservative, a pH adjuster, a water softener and the like.
【0080】本発明の処理方法の好ましい形態として、
現像液及び定着液の少なくとも1つが固形剤を溶解し、
希釈して調製された液である形態がある。固形剤とは固
体の処理剤のことであり、その形態は、錠剤、丸薬、顆
粒、粉末などの形態が挙げられる。ここで、粉末は微粒
結晶の集合体のことであり、顆粒は粉末を造粒したもの
であり、一般的には粒径50μm以上1000μmの粒
状物であり、錠剤は粉末又は顆粒などを一定の形状に圧
縮成型したものである。As a preferred embodiment of the treatment method of the present invention,
At least one of the developer and the fixer dissolves the solid agent;
There is a form which is a liquid prepared by dilution. The solid agent is a solid processing agent, and its form includes tablets, pills, granules, powders and the like. Here, the powder is an aggregate of fine crystals, the granule is a granulated powder, and is generally a granular material having a particle size of 50 μm or more and 1000 μm, and the tablet is a powder or a granule having a certain size. It is compression molded into a shape.
【0081】一回に供給される固形剤の量は、1g以上
が定量性の観点から好ましく、20g以下が現像液濃度
の安定性の観点から好ましい。特に、この範囲内では、
固形剤を現像液に直接補充し、ゆっくり溶解させながら
処理した場合でも写真状態には悪影響を与えない。何故
なら、固形剤は急激には溶解せずゆっくり溶解するため
に一回に添加する量が多くても処理しながら消費される
量と見合った組成にバランスするからである。The amount of the solid agent supplied at one time is preferably 1 g or more from the viewpoint of quantitativeness, and 20 g or less is preferable from the viewpoint of stability of the developer concentration. In particular, within this range,
Even if the solid agent is replenished directly to the developer and processed while slowly dissolving, it does not adversely affect the photographic condition. This is because the solid agent does not dissolve rapidly but dissolves slowly, so that even if the amount added at a time is large, the composition balances with the amount consumed during processing.
【0082】固形剤は予め一定量に分割秤量されている
ことが好ましい。「予め分割秤量された」とは、自現機
に固形剤をセットする以前に既に所定の一定量に分割秤
量されていることであり、例えば、所定の大きさの錠剤
や丸薬に成形されている態様、顆粒や粉末が所定量ずつ
小分けされ包装されている態様などが挙げられる。固形
剤が予め一定量に分割秤量されていると、補充精度が高
く極めて安定な連続処理性能が発揮される。It is preferable that the solid agent is previously divided and weighed into a predetermined amount. `` Pre-divided and weighed '' means that the solid agent has already been divided and weighed to a predetermined fixed amount before setting the solid agent in the automatic processing machine, for example, formed into tablets or pills of a predetermined size. And a mode in which granules or powder are subdivided into predetermined amounts and packaged. If the solid agent is divided and weighed in a predetermined amount in advance, replenishment accuracy is high and extremely stable continuous processing performance is exhibited.
【0083】錠剤の製造法としては、粉末状の固形剤を
造粒した後打錠する方法が、溶解性や保存性や写真性能
の安定の観点から、好ましい。錠剤形成のための造粒方
法は転動造粒、押し出し造粒、圧縮造粒、解砕造粒、攪
拌造粒、流動層造粒、噴霧乾燥造粒等公知の方法を用い
ることができる。次に得られた造粒物を打錠する際には
公知の打錠機、例えば油圧プレス機、単発式打錠機、ロ
ータリー式打錠機、プリケッテングマシンを用いること
ができる。As a method for producing a tablet, a method of granulating a powdered solid agent and then tableting is preferred from the viewpoints of solubility, storage stability and photographic performance stability. As a granulation method for tablet formation, known methods such as tumbling granulation, extrusion granulation, compression granulation, crushing granulation, stirring granulation, fluidized bed granulation, and spray drying granulation can be used. Next, when the obtained granules are tableted, a known tableting machine, for example, a hydraulic press, a single-shot tableting machine, a rotary tableting machine, or a pre-ketting machine can be used.
【0084】錠剤や丸薬は水溶性の防湿ポリマーで被覆
したり、あるいは防湿性のある材料を使用することによ
り防湿することができ、粉末や顆粒では個々の包装材料
に防湿性のある材料を選択することで防湿される。Tablets and pills can be moisture-proof by coating with a water-soluble moisture-proof polymer, or by using a moisture-proof material. For powders and granules, select a moisture-proof material for each packaging material. It is moisture-proof by doing.
【0085】固形剤から調製された処理液を用いて処理
する場合、ハロゲン化銀白黒写真感光材料の現像処理量
に応じて水を現像液に補充することが望ましい。この場
合、ハロゲン化銀白黒写真感光材料の現像処理量を検知
する処理量検出手段を自動現像機に設け、この処理量検
出手段により検出されたハロゲン化銀白黒写真感光材料
の現像処理量に応じて、固形剤の現像液への供給と水の
現像液への補充を制御することが望ましい。この場合、
水の現像液の補充は以下の3つの目的のために行われ
る。第1にハロゲン化銀白黒写真感光材料が処理される
際の反応によって溶出する蓄積有害抑制成分を希釈し濃
度を一定とすること、第2に処理したハロゲン化銀白黒
写真感光材料によって持ち出される水分あるいは前液か
ら持ち込まれた不要薬品を希釈し薄めること、第3にタ
ンク表面から蒸発した水分を補給することである。水は
補水タンクより供給すればよい。In the case of processing using a processing solution prepared from a solid agent, it is desirable to replenish water to the developing solution according to the development processing amount of the silver halide black-and-white photographic light-sensitive material. In this case, an automatic developing machine is provided with a processing amount detection means for detecting the development processing amount of the silver halide black-and-white photographic light-sensitive material, and according to the development processing amount of the silver halide black-and-white photographic light-sensitive material detected by the processing amount detection means. It is desirable to control the supply of the solid agent to the developer and the replenishment of water to the developer. in this case,
Replenishment of the water developer is performed for the following three purposes. First, the concentration of the accumulation harmful suppressing component eluted by the reaction during the processing of the silver halide black-and-white photographic light-sensitive material is adjusted to be constant, and secondly, the moisture taken out by the processed silver halide black-and-white photographic light-sensitive material. Alternatively, it is to dilute and dilute unnecessary chemicals brought in from the previous liquid, and thirdly, to supply water evaporated from the tank surface. Water may be supplied from a rehydration tank.
【0086】固形剤を供給する場所は処理液中であれば
よいが、好ましいのは、感光材料を処理する処理部と連
通し、該処理部との間を処理液が流通している場所であ
り、更に処理部との間に一定の処理液循環量があり溶解
した成分が処理部に移動する場所が好ましい。固形剤は
温調されている処理液中に投入されることが好ましい。
一般に自動現像機は温調のため、電気ヒーターにより処
理液を温調しており、処理部としての処理タンクと連結
した補助タンクに熱交換部を設け、ヒーターを設置しこ
の補助タンクには処理タンクから液を一定循環量で送り
込み、温度を一定ならしめるようポンプが配置されてい
る。この補助タンクの如き、処理部と連通した場所であ
って、温調が施された場所に固形剤が供給されるのが最
も好ましい方法である。The place where the solid agent is supplied may be any place in the processing liquid, but is preferably a place where the processing liquid communicates with the processing section for processing the photosensitive material and the processing liquid flows between the processing section and the processing section. In addition, it is preferable that there is a certain processing liquid circulation amount between the processing unit and the dissolved component moving to the processing unit. The solid agent is preferably introduced into the processing solution whose temperature is controlled.
Generally, the temperature of an automatic processor is controlled by an electric heater, and the temperature of the processing solution is controlled by an electric heater.A heat exchange unit is provided in an auxiliary tank connected to the processing tank as a processing unit, and a heater is installed. A pump is arranged so that the liquid is sent from the tank at a constant circulation amount and the temperature is kept constant. The most preferable method is to supply the solid agent to a place where the temperature is controlled, such as the auxiliary tank, which is in communication with the processing unit.
【0087】そして、この補助タンクに、処理液中に混
入した異物を取り除く目的でフィルターが配置されてい
ることが好ましい。何故なら供給された処理剤のうちの
不溶成分はフィルター部によって処理部とは遮断され、
不溶成分が処理部に流れ込み感光材料などに付着するこ
とが防止できるからである。It is preferable that a filter is disposed in the auxiliary tank for the purpose of removing foreign substances mixed in the processing liquid. Because the insoluble component of the supplied processing agent is cut off from the processing unit by the filter unit,
This is because it is possible to prevent the insoluble component from flowing into the processing section and attaching to the photosensitive material or the like.
【0088】循環される現像液の循環回数は、0.5回
/分以上(特に0.8回/分以上、さらに1.0回/分
以上)が好ましく、また、2.0回/分以下が好まし
い。これにより、固形剤の溶解が促進され、また、現像
液の高濃度液部分の発生を防止でき、処理された感光材
料の濃度ムラの発生を防止でき、また、処理不充分な感
光材料の発生を防止できる。The circulation frequency of the circulating developer is preferably 0.5 times / minute or more (especially 0.8 times / minute or more, more preferably 1.0 times / minute or more), and 2.0 times / minute. The following is preferred. As a result, the dissolution of the solid agent is promoted, the generation of a high-concentration liquid portion of the developing solution can be prevented, the occurrence of concentration unevenness in the processed photosensitive material can be prevented, and the generation of insufficiently processed photosensitive material can be prevented. Can be prevented.
【0089】[0089]
【実施例】以下、実施例を挙げて本発明を詳細に説明す
るが、本発明の実施態様はこれに限定されない。EXAMPLES The present invention will be described below in detail with reference to examples, but embodiments of the present invention are not limited thereto.
【0090】実施例1 以下、特に断りない限り、実施例中の「%」は「質量
%」を示す。Example 1 Hereinafter, unless otherwise specified, "%" in Examples indicates "% by mass".
【0091】 〈種乳剤−1の調製〉 A1 オセインゼラチン 24.2g 蒸留水 9657ml 界面活性剤AO−1(10%メタノール水溶液) 6.78ml 臭化カリウム 10.8g 10%硝酸 114ml B1 2.5mol/L硝酸銀水溶液 2825ml C1 臭化カリウム 841g 水で 2825mlに仕上げる D1 1.75mol/L臭化カリウム水溶液 下記銀電位制御量 AO−1:ポリプロピレンオキシ−ポリエチレンオキシ
−ジサクシネートナトリウム塩 42℃で特公昭58−58288号、同58−5828
9号に示される混合撹拌機を用いて、溶液(A1)に溶
液(B1)及び溶液(C1)の各々464.3mlを同
時混合法により1.5分を要して添加し、核形成を行っ
た。<Preparation of Seed Emulsion-1> A1 Ossein gelatin 24.2 g Distilled water 9657 ml Surfactant AO-1 (10% methanol aqueous solution) 6.78 ml Potassium bromide 10.8 g 10% nitric acid 114 ml B1 2.5 mol / L silver nitrate aqueous solution 2825 ml C1 Potassium bromide 841 g Finish up to 2825 ml with water D1 1.75 mol / L aqueous potassium bromide solution Silver potential control amount below AO-1: Polypropyleneoxy-polyethyleneoxy-disuccinate sodium salt 42 ° C. Nos. 58-58288 and 58-5828
Using a mixing stirrer described in No. 9, 464.3 ml of each of the solution (B1) and the solution (C1) was added to the solution (A1) by a simultaneous mixing method over 1.5 minutes, and nucleation was carried out. went.
【0092】溶液(B1)及び溶液(C1)の添加を停
止した後、40分の時間を要して溶液(A1)の温度を
50℃に上昇させ、3%水酸化カリウム水溶液でpHを
5.0に合わせた後、再び溶液(B1)と溶液(C1)
を同時混合法により、各々55.4ml/minの流量
で42分間添加した。この42℃から50℃への昇温及
び溶液(B1)、(C1)による再同時混合の間の銀電
位(飽和銀−塩化銀電極を比較電極として銀イオン選択
電極で測定)を、溶液(D1)を用いて、それぞれ+8
mV及び+16mVになるよう制御した。After stopping the addition of the solution (B1) and the solution (C1), it takes 40 minutes to raise the temperature of the solution (A1) to 50 ° C., and to adjust the pH to 5 with a 3% aqueous potassium hydroxide solution. After that, the solution (B1) and the solution (C1) were adjusted again.
Was added at a flow rate of 55.4 ml / min for 42 minutes by the double jet method. The silver potential (measured with a silver ion selective electrode using a saturated silver-silver chloride electrode as a reference electrode) during the temperature increase from 42 ° C. to 50 ° C. and the re-mixing with the solutions (B1) and (C1) was measured. +8 using D1)
mV and +16 mV.
【0093】添加終了後、3%水酸化カリウム水溶液で
pHを6に合わせ、直ちに脱塩、水洗を行った。この種
乳剤−1は、ハロゲン化銀粒子の全投影面積の90%以
上が最大隣接辺比が1.0〜2.0の六角平板状粒子よ
り成り、平均厚さは0.045μm、平均粒径(円直径
換算)は0.42μmであることを電子顕微鏡により確
認した。又、厚さの変動係数は42%、双晶面間距離の
変動係数は45%であった。After completion of the addition, the pH was adjusted to 6 with a 3% aqueous solution of potassium hydroxide, and immediately desalting and washing were performed. This seed emulsion-1 is composed of hexagonal tabular grains having a maximum adjacent side ratio of 1.0 to 2.0 at 90% or more of the total projected area of the silver halide grains, an average thickness of 0.045 μm, and an average grain size of 0.045 μm. It was confirmed by an electron microscope that the diameter (in terms of circular diameter) was 0.42 μm. The variation coefficient of the thickness was 42%, and the variation coefficient of the distance between twin planes was 45%.
【0094】〈平板状臭化銀乳剤の調製〉上記種乳剤−
1と以下に示す3種の溶液を用い、平板状純臭化銀乳剤
を調製した。 A2 オセインゼラチン 34.03g 界面活性剤AO−1(10%メタノール水溶液) 2.25ml 種乳剤−1 1.218モル相当 水で 3669mlに仕上げる B2 臭化カリウム 1747g 水で 3669mlに仕上げる C2 硝酸銀 2493g 水で 4193mlに仕上げる 反応容器内で溶液(A2)を50℃に保ちながら激しく
撹拌し、そこに溶液(B2)と溶液(C2)の全量を1
00分かけて同時混合法にて添加した。この間、pHは
水酸化カリウム水溶液により9.0に保ち、pAgは
8.6に終始保った。ここで溶液(B2)と溶液(C
2)の添加速度は、臨界成長速度に見合ったように時間
に対して関数的に変化させた。則ち、成長している種粒
子以外は小粒子の発生がないように、又、オストワルド
熟成により多成分化しないように、適切な添加速度で添
加した。<Preparation of tabular silver bromide emulsion>
A tabular pure silver bromide emulsion was prepared using the following three solutions. A2 Ossein gelatin 34.03 g Surfactant AO-1 (10% aqueous methanol solution) 2.25 ml Seed emulsion-1 1.218 mol equivalent Equivalent to 3669 ml with water B2 1747 g Potassium bromide Equivalent to 3669 ml with water 2493 g water silver nitrate In the reaction vessel, the solution (A2) was vigorously stirred while maintaining it at 50 ° C., and the total amount of the solution (B2) and the solution (C2) was reduced to 1 in the reaction vessel.
It was added by the double-mixing method over 00 minutes. During this time, the pH was kept at 9.0 with an aqueous potassium hydroxide solution, and the pAg was kept at 8.6 throughout. Here, the solution (B2) and the solution (C
The addition rate of 2) was changed functionally with respect to time to match the critical growth rate. That is, they were added at an appropriate addition rate so that no small particles were generated except for the seed particles that were growing, and that they did not become multi-components due to Ostwald ripening.
【0095】添加終了時後、この乳剤を40℃に冷却
し、凝集高分子剤としてフェニルカルバモイル基で変性
された(置換率90%)変性ゼラチン13.8%の水溶
液1800mlを添加し、3分間撹拌した。その後、5
6%酢酸水溶液を添加して乳剤のpHを4.6に調整
し、3分間撹拌した後、20分間静置させ、デカンテー
ションにより上澄液を排水し、更に蒸留水11.25L
を加え、撹拌静置後、上澄液を排水した。After completion of the addition, the emulsion was cooled to 40 ° C., and 1800 ml of an aqueous solution of 13.8% modified gelatin modified with a phenylcarbamoyl group (substitution rate: 90%) was added as an aggregating polymer, and the mixture was added for 3 minutes. Stirred. Then 5
The pH of the emulsion was adjusted to 4.6 by adding a 6% acetic acid aqueous solution, stirred for 3 minutes, allowed to stand for 20 minutes, the supernatant was drained by decantation, and 11.25 L of distilled water was further added.
, And the mixture was stirred and allowed to stand, and then the supernatant was drained.
【0096】続いて、ゼラチン水溶液と10%炭酸ナト
リウム水溶液を加えてpHが5.80になるように調整
し、50℃で30分間撹拌し再分散した。再分散後、4
0℃にてpHを5.80、pAgを8.06に調整し
た。Subsequently, an aqueous solution of gelatin and an aqueous solution of 10% sodium carbonate were added to adjust the pH to 5.80, followed by stirring at 50 ° C. for 30 minutes to redisperse. After redistribution, 4
The pH was adjusted to 5.80 and the pAg to 8.06 at 0 ° C.
【0097】得られた臭化銀乳剤を電子顕微鏡にて観察
したところ、平均粒径0.84μm、平均厚さ0.16
μm、平均アスペクト比約5.3、粒径分布の広さ20
%の平板状粒子であった。又、物理熟成終了時のゼラチ
ン量は、ハロゲン化銀1モル当たり15.9gであっ
た。When the obtained silver bromide emulsion was observed with an electron microscope, the average particle diameter was 0.84 μm and the average thickness was 0.16.
μm, average aspect ratio about 5.3, particle size distribution width 20
% Tabular grains. The amount of gelatin at the end of the physical ripening was 15.9 g per mol of silver halide.
【0098】〈ハロゲン化銀乳剤Aの調製〉上記で調製
した乳剤を55℃にした後、ハロゲン化銀1モル当たり
アデニン11.3mg、下記分光増感色素(A)450
mg、分光増感色素(B)45mgを添加し、更に安定
剤(ST−1)100mgを添加した。その後10分し
て、塩化金酸を3.5mg、チオ硫酸ナトリウムを10
mg、チオシアン酸アンモニウム100mg添加した。
更に40分後に、下記の沃化銀微粒子乳剤を沃化銀0.
3モル相当量添加し、更に10分後にトリフェニルホス
フィンセレニド5mgを添加し、更に40分後に(ST
−1)500mgを添加し、5分後にトリメチロールプ
ロパン13g、ゼラチン30gを添加してから急速冷却
し、乳剤をゲル化して化学増感を終了した。この乳剤を
ハロゲン化銀乳剤Aとする。<Preparation of Silver Halide Emulsion A> The emulsion prepared above was heated to 55 ° C., 11.3 mg of adenine per mol of silver halide, and 450 spectral sensitizing dyes (A) shown below.
mg and 45 mg of spectral sensitizing dye (B), and 100 mg of stabilizer (ST-1) were further added. After 10 minutes, 3.5 mg of chloroauric acid and 10 mg of sodium thiosulfate were added.
mg and 100 mg of ammonium thiocyanate.
After a further 40 minutes, the following silver iodide fine grain emulsion was added to a silver iodide 0.
3 mol equivalent amount, and 10 minutes later, 5 mg of triphenylphosphine selenide was added, and 40 minutes later (ST
-1) 500 mg was added, and after 5 minutes, 13 g of trimethylolpropane and 30 g of gelatin were added, followed by rapid cooling to gel the emulsion to complete the chemical sensitization. This emulsion is designated as silver halide emulsion A.
【0099】増感色素(A):5,5′−ジ−クロロ−
9−エチル−3,3′−ジ−(3−スルホプロピル)オ
キサカルボシアニンナトリウム塩の無水物 増感色素(B):5,5′−ジ−(ブトキシカルボニ
ル)−1,1′−ジエチル−3,3′−ジ−(4−スル
ホブチル)ベンゾイミダゾロカルボシアニンナトリウム
塩の無水物 ST−1:4−ヒドロキシ−6−メチル−1,3,3
a,7−テトラザインデン 〈沃化銀微粒子の調製〉 A3 オセインゼラチン 100g 沃化カリウム 8.5g 蒸留水で 2000mlにする B3 硝酸銀 360g 蒸留水で 605mlにする C3 沃化カリウム 352g 蒸留水で 605mlにする 反応容器に溶液(A3)を加え、40℃に保ち撹拌しな
がら、溶液(B3)及び溶液(C3)を同時混合法によ
り30分を要して定速で添加した。添加中のpAgは常
法のpAg制御手段で13.5に保った。Sensitizing dye (A): 5,5'-di-chloro-
Anhydride of sodium salt of 9-ethyl-3,3'-di- (3-sulfopropyl) oxacarbocyanine Sensitizing dye (B): 5,5'-di- (butoxycarbonyl) -1,1'-diethyl -3,3'-Di- (4-sulfobutyl) benzimidazolocarbocyanine sodium salt anhydride ST-1: 4-hydroxy-6-methyl-1,3,3
a, 7-Tetrazaindene <Preparation of silver iodide fine particles> A3 ossein gelatin 100 g Potassium iodide 8.5 g Make up to 2000 ml with distilled water B3 Silver nitrate 360 g Make up to 605 ml with distilled water C3 352 g Potassium iodide 605 ml with distilled water The solution (A3) was added to the reaction vessel, and the solution (B3) and the solution (C3) were added at a constant speed by a simultaneous mixing method over 30 minutes while stirring at 40 ° C. The pAg during the addition was kept at 13.5 by a conventional pAg control means.
【0100】生成した沃化銀は平均粒径0.06μmの
β−AgIとγ−AgIの混合物であった。この乳剤を
沃化銀微粒子乳剤と言う。The resulting silver iodide was a mixture of β-AgI and γ-AgI having an average grain size of 0.06 μm. This emulsion is called a silver iodide fine grain emulsion.
【0101】〈下引済み支持体の作製〉厚さ175μm
で濃度0.20に青色着色したポリエチレンテレフタレ
ート(PET)ベースの両側に、8Wmin/m2のコ
ロナ放電処理をした後、下引きを塗布し、110℃で1
分間乾燥し下引済み支持体を得た。<Preparation of Subbed Support> Thickness 175 μm
After a corona discharge treatment of 8 Wmin / m 2 was applied to both sides of a polyethylene terephthalate (PET) base colored blue at a concentration of 0.20 with an undercoat, an undercoat was applied.
After drying for a minute, a subbed support was obtained.
【0102】〈感光材料の作製〉得られた下引済み支持
体の両面に、支持体に近い方(染料層)から第1層と
し、下記の第1層〜第3層を3層同時塗布した。<Preparation of photosensitive material> The following first to third layers were simultaneously coated on both sides of the obtained undercoated support as the first layer from the side closer to the support (dye layer). did.
【0103】第1層(染料層) 各素材の片面1m2当たりの添加量を示す。[0103] The first layer (dye layer) indicating the amount of one side 1 m 2 per each material.
【0104】 石灰処理イナートゼラチン 0.1g/片面m2 フィルター染料F(固体分散) 70mg/片面m2 ポリマーラテックスL(ガラス転位点40℃) 70mg/片面m2 粘度調整剤V−1 粘度10mPa・sとなる量 第2層(乳剤層) ハロゲン化銀乳剤A 銀量として1.35g/片面m2 親水性ポリマー:石灰処理イナートゼラチンとデキストラン(平均分子量:4 万)が90:10の比率 1.9g/片面m2 1,1−ジメチロール−1−ブロム−1−ニトロメタン 70mg/AgXモル ニトロフェニル−トリフェニルホスホニウムクロリド 2.8mg/AgXモル C4H9OCH2CH(OH)CH2N(CH2COOH)2 1.0g/AgXモル カブリ防止剤(AF−1) 8.5mg/AgXモル コロイダルシリカ(ヂュポン社製ルドックスAM) 13g/AgXモル t−ブチルカテコール 150mg/AgXモル 1,3−ジヒドロキシベンゼン−4−スルホン酸アンモニウム 1.7g/AgXモル カブリ防止剤(AF−2) 15mg/AgXモル 硝酸タリウム 55mg/AgXモル トリメチロールプロパン 6.5g/AgXモル 粘度調整剤(V−1) 粘度30mPa・sとなる量 第3層(保護層) 硬膜剤以外は片面1m2当たりの付量で示す。Lime-treated inert gelatin 0.1 g / one side m 2 Filter dye F (solid dispersion) 70 mg / one side m 2 Polymer latex L (glass transition point 40 ° C.) 70 mg / one side m 2 Viscosity modifier V-1 Viscosity 10 mPa · s and qs second layer (emulsion layer) silver halide emulsion a silver amount as 1.35 g / one side m 2 hydrophilic polymer: lime-treated inert gelatin and dextran (average molecular weight: 40,000) is 90:10 ratio 1 0.9 g / m 2 on one side 1,1-dimethylol-1-bromo-1-nitromethane 70 mg / AgX mol Nitrophenyl-triphenylphosphonium chloride 2.8 mg / AgX mol C 4 H 9 OCH 2 CH (OH) CH 2 N ( CH 2 COOH) 2 1.0 g / AgX mol Antifoggant (AF-1) 8.5 mg / AgX mol Colloidal silica (ヂ13 g / AgX mol 150 mg / AgX mol 1,3-dihydroxybenzene-4-sulfonic acid ammonium 1.7 g / AgX mol Antifoggant (AF-2) 15 mg / AgX mol thallium nitrate 55 mg / AgX mol Trimethylolpropane 6.5 g / AgX mol Viscosity modifier (V-1) Amount that gives a viscosity of 30 mPa · s Third layer (protective layer) Except for the hardener, the amount is shown per 1 m 2 per side.
【0105】 石灰処理イナートゼラチン 0.6g/片面m2 ソジウム・ジヘキシルスルホサクシネート 5mg/片面m2 ソジウム・(アミル・デシル)スルホサクシネート 3mg/片面m2 C11H23CONH(CH2CH2O)5H 5mg/片面m2 ソジウム・ジ(2,2,3,3,4,4,5,5,6,6,7,7 −ドデシルフルオロヘプチル)スルホサクシネート 1.2mg/片面m2 p−C8H17−C6H4−O(CH2CH2O)4−SO3Na 15mg/片面m2 C16H33O(CH2CH2O)10H 15mg/片面m2 C11H23CON[(CH2CH2O)mH](CH2CH2O)nH (m+n=10) 40mg/片面m2 フッ素系界面活性剤(本発明の一般式(1)、(2)の化合物、および比較の 化合物)(表1記載) 表1記載の量 カブリ防止剤(AF−3) 3mg/片面m2 防腐剤(DF−1) 1mg/片面m2 ポリメチルメタクリレートからなるマット剤(平均粒径3.3μm) 30mg/片面m2 尚、硬膜剤(H−1)を、1〜3層の全親水性ポリマー
に対して25mg/g添加した。[0105] lime-treated inert gelatin 0.6 g / one side m 2 Sodium-dihexyl sulfosuccinate 5mg / single-sided m 2 Sodium · (amyl-decyl) sulfosuccinate 3 mg / simplex m 2 C 11 H 23 CONH ( CH 2 CH 2 O) 5 H 5 mg / one side m 2 Sodium di (2,2,3,3,4,4,5,5,6,6,7,7-dodecylfluoroheptyl) sulfosuccinate 1.2 mg / one side m 2 p-C 8 H 17 -C 6 H 4 -O (CH 2 CH 2 O) 4 -SO 3 Na 15mg / single-sided m 2 C 16 H 33 O ( CH 2 CH 2 O) 10 H 15mg / single-sided m 2 C 11 H 23 CON [(CH 2 CH 2 O) m H] (CH 2 CH 2 O) n H (m + n = 10) 40mg / single-sided m 2 fluorine-based surfactant (compound represented by formula (1), (Compound of (2) and Comparative Compound) (Table 1) Description) Amount described in Table 1 Antifoggant (AF-3) 3 mg / one-sided m 2 Preservative (DF-1) 1 mg / one-sided m 2 Matting agent composed of polymethyl methacrylate (average particle size 3.3 μm) 30 mg / one-sided m 2 The hardener (H-1) was added in an amount of 25 mg / g to all the hydrophilic polymers in 1 to 3 layers.
【0106】V−1:ポリスチレンスルホン酸ナトリウ
ム(Mw≒50万) AF−1:1−フェニル−5−メルカプトテトラゾール AF−2:1−(3−ソジウムスルホナトフェニル)−
5−メルカプトテトラゾール AF−3:1−(4−ソジウムカルボキシラトフェニ
ル)−5−メルカプトテトラゾール H−1:1,2−ビス(ビニルスルホニルアセトアミ
ド)エタンV-1: Sodium polystyrene sulfonate (Mw = 500,000) AF-1: 1-Phenyl-5-mercaptotetrazole AF-2: 1- (3-Sodium sulfonatophenyl)-
5-mercaptotetrazole AF-3: 1- (4-sodiumcarboxylatophenyl) -5-mercaptotetrazole H-1: 1,2-bis (vinylsulfonylacetamide) ethane
【0107】[0107]
【化5】 Embedded image
【0108】〈処理剤の調製〉 〈ハイドロキノンを現像主薬とする固形現像剤αの作
製〉下記に示す方法に従い、固形現像剤αを作製した。
なお、表示した数値は、現像液として使用するときの1
00リットル量分である。<Preparation of processing agent><Preparation of solid developer α using hydroquinone as a developing agent> A solid developer α was prepared according to the method described below.
In addition, the displayed value is 1 when used as a developer.
It is equivalent to 00 liters.
【0109】(造粒物Aの作製)ハイドロキノン(以
降、HQと略す)3000g、フェニドン400g、硼
酸1000g、N−アセチル−D,L−ペニシラミン1
0g及びグルタルアルデヒド重亜硫酸ナトリウム800
gを、それぞれ市販のバンタムミル中で、平均粒径が1
0μmになるまで粉砕した。この微粉体に、亜硫酸ナト
リウム700g、結合剤としてD−ソルビット200g
を加え、バンタムミル中で30分混合し、市販の攪拌造
粒機中で室温にて約5分間、30mlの水を添加するこ
とにより造粒した後、造粒物を流動層乾燥機で40℃に
て2時間乾燥して造粒物の水分をほぼ完全に除去し、造
粒物Aを作製した。(Preparation of Granulated Material A) Hydroquinone (hereinafter abbreviated as HQ) 3000 g, phenidone 400 g, boric acid 1000 g, N-acetyl-D, L-penicillamine 1
0 g and sodium glutaraldehyde bisulfite 800
g in a commercially available bantam mill, each having an average particle size of 1
Crushed to 0 μm. 700 g of sodium sulfite and 200 g of D-sorbit as a binder were added to this fine powder.
, And mixed in a bantam mill for 30 minutes, and granulated by adding 30 ml of water at room temperature for about 5 minutes in a commercially available stirring granulator. For 2 hours to remove the water content of the granulated product almost completely, thereby producing a granulated product A.
【0110】(造粒物Bの作製)炭酸カリウム5300
g、重炭酸カリウム50g、臭化カリウム200gを、
それぞれ市販のバンタムミル中で平均粒径が10μmに
なるまで粉砕した。この微粉体に、水酸化リチウム・水
和物200g、ジエチレン−トリアミン5酢酸(DTP
A・5H)250g、1−フェニル−5−メルカプトテ
トラゾール5g、亜硫酸ナトリウム4000g、結合剤
マンニトール1000gを加え、バンタムミル中で30
分混合して、市販の攪拌造粒機中で室温にて約15分
間、30mlの水を添加することにより造粒した後、造
粒物を流動層乾燥機により40℃で2時間乾燥して造粒
物の水分をほぼ完全に除去し、造粒物Bを作製した。(Preparation of granulated substance B) Potassium carbonate 5300
g, potassium bicarbonate 50 g, potassium bromide 200 g,
Each was pulverized in a commercially available bantam mill until the average particle size became 10 μm. 200 g of lithium hydroxide hydrate and diethylene-triaminepentaacetic acid (DTP) were added to this fine powder.
A.5H) 250 g, 1-phenyl-5-mercaptotetrazole 5 g, sodium sulfite 4000 g, and binder mannitol 1000 g were added, and the mixture was added to a bantam mill.
After mixing and granulating by adding 30 ml of water for about 15 minutes at room temperature in a commercially available stirring granulator, the granulated product is dried at 40 ° C. for 2 hours by a fluidized bed drier. The water in the granulated product was almost completely removed, and a granulated product B was produced.
【0111】(固形現像剤αの作製)上記造粒物A、B
それぞれにそれぞれの質量の3%となるように1−オク
タンスルホン酸ナトリウムを添加し、それぞれ個別に2
5℃で40%RH以下に調湿された部屋で混合機を用い
て10分間均一に混合した後、得られた各混合物をタフ
プレスコレクト1527HU(菊水製作所社製)を改造
した打錠機により、1錠当たりの充填量として、造粒物
Aでは10.09g、造粒物Bでは9.5gとなるよう
調整して、圧縮打錠を行い、直径30mmの円筒形の各
現像液用錠剤を作製した。各錠剤A、Bを防湿のためア
ルミを含有させたピロー袋一つにそれぞれ現像液として
現像液3.5リットル相当量分ずつ封入包装した。これ
らを固形現像剤αとする。(Preparation of Solid Developer α) The above granulated materials A and B
Sodium 1-octanesulfonate was added to each so as to be 3% of the mass of each, and 2
After uniformly mixing for 10 minutes using a mixer in a room humidified at 5 ° C. and 40% RH or less, each of the obtained mixtures was mixed with a tableting machine modified from Tough Press Collect 1527HU (manufactured by Kikusui Seisakusho Co., Ltd.). Each tablet was adjusted so as to have a filling amount of 10.09 g for the granulated product A and 9.5 g for the granulated product B, and compression tableting was performed. Was prepared. Each of the tablets A and B was sealed and packaged in a pillow bag containing aluminum for moisture proofing in an amount equivalent to 3.5 liters of a developing solution. These are referred to as solid developers α.
【0112】〈エリソルビン酸(本発明の例示化合物3
−1)を現像主薬とする固形現像剤βの作製〉下記に示
す方法に従い、固形現像剤βを作製した。なお、表示し
た数値は、現像液として使用するときの100リットル
量分である。<Erythorbic acid (Exemplified compound 3 of the present invention)
Preparation of solid developer β using -1) as a developing agent> A solid developer β was prepared according to the method described below. In addition, the displayed numerical value is the amount of 100 liters when used as a developer.
【0113】(造粒物Cの作製)フェニドン400g、
N−アセチル−D,L−ペニシラミン10g、グルタル
アルデヒド重亜硫酸ナトリウム800gを、夫々市販の
バンタムミル中で平均10μmになるまで粉砕する。こ
の微粉にメタ重亜硫酸ナトリウム1500g、エリソル
ビン酸ソーダ(以降、ERと略す)6800g、結合剤
D−ソルビット600gを加え、ミル中で30分混合し
て市販の攪拌造粒機中で室温にて約10分間、30ml
の水を添加することにより造粒した後、造粒物を流動層
乾燥機にて40℃で2時間乾燥して造粒物の水分をほぼ
完全に除去して、造粒物Cを作製した。(Preparation of granulated product C) 400 g of phenidone,
10 g of N-acetyl-D, L-penicillamine and 800 g of sodium glutaraldehyde bisulfite are each ground in a commercially available bantam mill to an average of 10 μm. To this fine powder, 1500 g of sodium metabisulfite, 6800 g of sodium erythorbate (hereinafter abbreviated as ER), and 600 g of a binder D-sorbite were added, mixed in a mill for 30 minutes, and mixed at room temperature in a commercial stirring granulator. 30 minutes for 10 minutes
After granulation by adding water, the granulated product was dried at 40 ° C. for 2 hours in a fluidized bed drier to almost completely remove the moisture of the granulated product, thereby producing a granulated product C. .
【0114】(造粒物Dの作製)炭酸カリウム1030
0g、重炭酸カリウム100gを、それぞれ市販のバン
タムミル中で平均粒径が10μmのなるまで粉砕した。
この微粉体に、ジエチレン−トリアミン5酢酸ナトリウ
ム(DTPA・5Na)を500g、950g、下記化
合物AF−1を40g、下記化合物AF−2を10g、
沃化カリウム7g、メチル−β−シクロデキストリン2
00g、結合剤としてマンニトール2000g、D−ソ
ルビット700gを加え、バンタムミル中で30分混合
して、市販の攪拌造粒機中で室温にて約15分間、30
mlの水を添加することにより造粒した後、造粒物を流
動層乾燥機にて40℃で2時間乾燥して造粒物の水分を
ほぼ完全に除去して、造粒物Dを作製した。(Preparation of Granules D) Potassium carbonate 1030
0 g and 100 g of potassium bicarbonate were each pulverized in a commercially available bantam mill until the average particle size became 10 μm.
To this fine powder, 500 g and 950 g of diethylene-triamine sodium pentaacetate (DTPA · 5Na), 40 g of the following compound AF-1, 10 g of the following compound AF-2,
7 g of potassium iodide, methyl-β-cyclodextrin 2
Then, 2000 g of mannitol and 700 g of D-sorbite were added as binders, mixed in a bantam mill for 30 minutes, and placed in a commercially available stirring granulator at room temperature for about 15 minutes.
After granulating by adding ml of water, the granulated product is dried at 40 ° C. for 2 hours in a fluidized bed drier to almost completely remove the water content of the granulated product to produce a granulated product D did.
【0115】化合物AF−1:1−(3−スルホフェニ
ル)−5−メルカプトテトラゾール・ナトリウム 化合物AF−2:5−メルカプト−(1H)−テトラゾ
リル酢酸ナトリウム (固形現像剤βの作製)上記造粒物CとDそれぞれにそ
れぞれの質量の1.3%となるように1−オクタンスル
ホン酸ナトリウムを添加し、それぞれ個別に個別に25
℃で40%RH以下に調湿された部屋で混合機を用いて
10分間均一に混合した後、上記固形現像剤αと同様
に、充填量として造粒物Cは10.0g、造粒物Dは1
0.0gとなるように圧縮打錠を行い、直径30mmの
円筒形の各現像錠剤を作製した。作製した錠剤C、錠剤
Dを防湿のため、アルミを含有させたピロー袋一つに現
像液3.5リットル相当量分ずつ封入包装した。これら
を固形現像剤βとする。Compound AF-1: sodium 1- (3-sulfophenyl) -5-mercaptotetrazole Compound AF-2: sodium 5-mercapto- (1H) -tetrazolylacetate (Preparation of solid developer β) Sodium 1-octanesulfonate was added to each of the products C and D so as to make 1.3% of the mass of each, and 25
After uniformly mixing for 10 minutes using a mixer in a room conditioned at 40 ° C. or less at 40 ° C., 10.0 g of granulated material C and granulated material were filled in the same manner as the solid developer α. D is 1
The tablets were compressed and compressed to 0.0 g to produce cylindrical developing tablets having a diameter of 30 mm. The tablets C and D thus prepared were sealed in a pillow bag containing aluminum in an amount equivalent to 3.5 liters of the developing solution for moisture prevention. These are referred to as solid developers β.
【0116】〈固形定着錠剤の作製〉以下に示す方法に
従い、定着液として100リットル相当量になる固形定
着錠剤を作製した。<Preparation of solid fixing tablet> A solid fixing tablet corresponding to 100 liters as a fixing solution was prepared according to the method described below.
【0117】(造粒物Eの作製)チオ硫酸アンモニウム
/チオ硫酸ナトリウム(90/10質量比)15000
gを市販のバンタムミル中で平均粒径が10μmになる
まで粉砕した。この微粉体にメタ重亜硫酸ナトリウム9
00g、結合剤としてパインフロー1300gを加え、
水を50ml添加して攪拌造粒を行い、造粒物を流動層
乾燥機にて40℃で乾燥して水分をほぼ完全に除去し
て、造粒物Eを作製した。(Preparation of Granulated Material E) Ammonium thiosulfate / sodium thiosulfate (90/10 mass ratio) 15000
g was ground in a commercially available bantam mill until the average particle size became 10 μm. Sodium metabisulfite 9
00 g, 1300 g of pine flow as a binder,
50 ml of water was added to perform stirring and granulation, and the granulated product was dried at 40 ° C. using a fluidized bed drier to almost completely remove water, thereby producing a granulated product E.
【0118】(造粒物Fの作製)硫酸アルミニウム・8
水塩1500g、琥珀酸1200g、硼酸250g、酒
石酸300g、グルコン酸ナトリウム200gを市販の
バンタムミル中で平均粒径が10μmになるまで粉砕し
た。この微粉体にD−マンニット250g、D−ソルビ
ット120gを加え、水を30ml添加して攪拌造粒を
行い、造粒物を流動層乾燥機にて40℃で乾燥して水分
をほぼ完全に除去して、造粒物Fを作製した。(Preparation of Granulated Material F) Aluminum Sulfate · 8
1500 g of water salt, 1200 g of succinic acid, 250 g of boric acid, 300 g of tartaric acid and 200 g of sodium gluconate were ground in a commercially available bantam mill until the average particle size became 10 μm. 250 g of D-mannitol and 120 g of D-sorbite are added to this fine powder, and 30 ml of water is added to carry out stirring granulation, and the granulated material is dried at 40 ° C. in a fluidized bed drier to almost completely remove water. After removal, a granulated material F was produced.
【0119】以上のようにして作製した造粒物Eに、β
−アラニン3000g、酢酸ナトリウム1400g、更
に1−ヘキサンスルホン酸ナトリウムを総質量の3.0
%になるように添加し、更に造粒物Fには、酢酸ナトリ
ウム1500gと1−ヘキサンスルホン酸ナトリウムを
総質量の3.0%となるように添加し、それぞれ25℃
で40%RH以下に調湿された部屋で混合機を用いて1
0分間均一に混合した後、得られた各混合物を菊水製作
所社製タフプレスコレクト1527HUを改造した打錠
機により、1錠当たりの充填量として、造粒物Eは1
0.2g、造粒物Fは11.2gとなるように圧縮打錠
を行い、直径30mmの円筒形の各固形定着錠剤を作製
した。The granulated product E prepared as described above was added to β
3000 g of alanine, 1400 g of sodium acetate, and sodium 1-hexanesulfonate in a total mass of 3.0 g.
%, And to the granulated product F, 1500 g of sodium acetate and sodium 1-hexanesulfonate were added so as to be 3.0% of the total mass.
Using a mixer in a room humidified to 40% RH or less
After uniformly mixing for 0 minutes, each of the obtained mixtures was converted into a granule E in an amount of 1 per tablet using a tableting machine modified from Tough Press Collect 1527HU manufactured by Kikusui Seisakusho Co., Ltd.
Compression tableting was performed so that 0.2 g of the granulated product F and 11.2 g of the granulated product F were prepared, thereby producing cylindrical solid fixing tablets having a diameter of 30 mm.
【0120】各固形定着錠剤を防湿のため、アルミを含
有させたピロー袋一つに定着液3.5リットル相当量分
ずつ封入包装した。これらを固形定着錠剤(E+F)と
する。 〈処理及び評価〉上記で得られた感光材料を用いて濃度
1.0になるように均一露光を施し、これを自動現像機
TCX−201(コニカ(株)製)、SRX−101
(コニカ(株)製)を用い、ランニング処理を行った。Each solid fixing tablet was sealed and packed in a pillow bag containing aluminum in an amount equivalent to 3.5 liters of fixing solution to prevent moisture. These are designated as solid fixing tablets (E + F). <Processing and Evaluation> The photosensitive material obtained above was subjected to uniform exposure so as to have a density of 1.0, and was subjected to automatic developing machine TCX-201 (manufactured by Konica Corporation) and SRX-101.
Using Konica Corporation, a running process was performed.
【0121】TCX−201については1日当たりの稼
働時間は24時間とし、1日当たり四つ切りサイズ20
0枚処理を3ヶ月継続した。尚、スタンバイ時間は30
分とした。For TCX-201, the operating time per day is 24 hours, and the size of the quadruple per day is 20 hours.
Zero-sheet processing was continued for three months. The standby time is 30
Minutes.
【0122】SRX−101については1日当たりの稼
働時間は10時間とし、1日当たりの四つ切りサイズ6
枚処理を6ヶ月継続した。尚、スタンバイ時間は10分
とした。For the SRX-101, the operating time per day is 10 hours, and the size per quarter per day is 6
The sheet processing was continued for 6 months. The standby time was 10 minutes.
【0123】処理条件は以下の通りである。 TCX−201 SRX−101 現像温度 36℃ 34℃ 定着温度 36℃ 34℃ 水洗温度 18℃(水道水温度) 18℃(水道水温度) 乾燥温度 55℃ 55℃ 処理時間 60秒 90秒 補充量(現像/定着) 180/180(ml/m2) 180/180(ml/m2) SRX−101は現像処理槽の開口比(開口部分面積/
体積)が0.01になるように現像ラック及び槽に酸化
防止板を加える改造を施した。改造によって現像処理性
に影響しないことは確認した。The processing conditions are as follows. TCX-201 SRX-101 Developing temperature 36 ° C 34 ° C Fixing temperature 36 ° C 34 ° C Washing temperature 18 ° C (tap water temperature) 18 ° C (tap water temperature) Drying temperature 55 ° C 55 ° C Processing time 60 seconds 90 seconds Replenishment amount (development / Fixing) 180/180 (ml / m 2 ) 180/180 (ml / m 2 ) SRX-101 has an opening ratio (opening area /
(Volume) was adjusted to 0.01 by adding an antioxidant plate to the developing rack and the tank. It was confirmed that the remodeling did not affect the development processability.
【0124】ケミカルミキサーとしてはTCX−M50
(コニカ(株)製)を現像固形剤α、β及び定着固形剤
の3.5L量が溶解できるように小型に改造し、補充液
を供給するサブタンク槽(調液後ストックされる槽:7
L容積)の開口比が0.005以下になるように酸化防
止板を設けた。固形剤は上記ケミカルミキサーにて調液
された後サブタンクに移動され、補充液として供給され
る。サブタンク内の処理液が残容量3.0Lになると次
の固形剤3.5L量がケミカルミキサーにて調液され
る。TCX−201は本来内部ケミカルミキサータイプ
であるが外部ケミカルミキサー仕様に変更し上記改造し
たTCX−M50(ケミカルミキサー)と接続した。As a chemical mixer, TCX-M50 is used.
(Manufactured by Konica Corporation) was remodeled into a small size so that 3.5 L of the developing solid agents α and β and the fixing solid agent could be dissolved, and a sub-tank tank for supplying a replenisher (tank stocked after the preparation: 7)
An antioxidant plate was provided so that the opening ratio of (L volume) was 0.005 or less. After the solid agent is prepared by the chemical mixer, it is moved to the sub tank and supplied as a replenisher. When the remaining volume of the processing liquid in the sub tank reaches 3.0 L, the next 3.5 L of the solid agent is prepared by a chemical mixer. The TCX-201 was originally an internal chemical mixer type, but was changed to an external chemical mixer specification and connected to the modified TCX-M50 (chemical mixer).
【0125】現像処理の開始はTCX−201の場合は
現像補充液7.8Lを入れ、後記のスターターを加えて
スタート液として現像槽を満たし、SRX−101の場
合は現像補充液3.9Lを入れ同じスターターを加えて
スタート液として現像槽を満たし、定着槽についてはT
CX−201の場合は7.5L、SRX−101の場合
は1.9L量で定着液を満たして行った。現像処理開始
液のpHについてはTCX−201の場合はpH9.8
0、SRX−101の場合はpH9.60とした。In the case of TCX-201, 7.8 L of development replenisher was added, and a starter described later was added to fill the developing tank as a start solution. In the case of SRX-101, 3.9 L of development replenisher was added. Add the same starter and fill the developing tank as a start solution.
The fixing solution was filled with 7.5 L in the case of CX-201 and 1.9 L in the case of SRX-101. Regarding the pH of the development start solution, in the case of TCX-201, pH 9.8.
0 and SRX-101, pH 9.60.
【0126】 (スターター処方) 現像液1Lに対する添加量 臭化カリウム 5.5g HO−CH2CH2SCH2CH2SCH2CH2−OH 0.05g Nーアセチル−D,L−ぺニシラミン 0.10g メタ重亜硫酸ナトリウム 開始液pHになる量 水で 60ml仕上げ 〈濃度ムラの評価〉濃度1.0、1.35、1.7に均
一に露光を施した大角サイズ3枚を準備し自動現像機T
CX−201では1ヶ月後と3ヶ月後に処理を行い、自
動現像機SRX−101では3ヶ月後と6ヶ月後に処理
を行い、下記の評価基準に従い濃度ムラを目視で評価し
た。(Starter Formulation) Amount Added to 1 L of Developer 5.5 g of Potassium Bromide HO-CH 2 CH 2 SCH 2 CH 2 SCH 2 CH 2 —OH 0.05 g N-acetyl-D, L-penicillamine 0.10 g Sodium metabisulfite Amount to be the pH of the starting solution 60 ml finished with water <Evaluation of density unevenness> Prepare three large-size sheets uniformly exposed to densities of 1.0, 1.35 and 1.7, and prepare an automatic developing machine T
The CX-201 was processed after 1 month and 3 months, and the automatic developing machine SRX-101 was processed after 3 months and 6 months. Density unevenness was visually evaluated according to the following evaluation criteria.
【0127】 5:濃度ムラが認められない 4:僅かにムラらしきものが見受けられるが診断上支障
は無い 3:部分的に薄い濃度で濃度ムラが発生。実用下限ぎり
ぎりのレベル 2:薄い濃度で全面に濃度ムラが発生 1:濃い濃度で全面に明確に濃度ムラが発生 〈画像欠陥および未露光フィルムの故障の評価〉自動現
像機TCX−201では3ヶ月後の3日間を選択し、自
動現像機SRX−101では6ヶ月後の3日間を選択し
て共に3日間の中でランニング処理しているフィルム
(濃度1.0になるように均一露光を施してある)から
10枚ランダムに選択して画像欠陥の評価を行った。5: No unevenness in density was observed. 4: Somewhat seemed to be uneven, but there was no problem in diagnosis. 3: Unevenness in density occurred at a partially low density. Level near the lower limit of practical use 2: Density unevenness occurs over the entire surface at low density 1: Density unevenness occurs over the entire surface at high density <Evaluation of image defects and failure of unexposed film> Three months with TCX-201 automatic developing machine The following three days are selected, and in the automatic developing machine SRX-101, the three days after six months are selected, and the film which is running during the three days (the uniform exposure is performed so that the density becomes 1.0) ) Were randomly selected from 10) to evaluate image defects.
【0128】また、同時に未露光フィルムについても処
理し、銀スラッジ付着、結晶付着による乳剤残りなどの
未露光フィルム故障の評価を行った。 画像欠陥の評価基準 5:全くポチ状欠陥が無く、汚れも認められない 4:診断上支障となるポチ状欠陥は無いが部分的に汚れ
付着がある 3:端の方で濃度がポチ状に数ヶ所抜けて(ポチ状欠
陥)いたり、汚れ付着が若干ある 2:濃度が抜けていたり、逆に濃度が高くなっていたり
するポチ状欠陥が認められポチのサイズは小さいが数は
やや多い 1:サイズの大きいポチ状欠陥(濃度欠落、濃度アップ
(+0.5))が数多く全面に見受けられ、銀スラッジ
付着も多い 未露光フィルムの故障の評価基準 3:銀スラッジ付着も乳剤残りも無い 2:数カ所、小さい乳剤残りがある 1:銀スラッジ付着が多く、乳剤残りが全面に認められ
る 以上の経過および結果を表1に示す。At the same time, the unexposed film was processed to evaluate the failure of the unexposed film such as adhesion of silver sludge and remaining emulsion due to crystal attachment. Evaluation criteria for image defects 5: No spot defects at all, no stains found 4: No spot defects that could interfere with diagnosis, but partial stain adhesion 3: Density at edges Some spots are missing (pocket-like defects), and some dirt is adhered. 2: Spot-like defects such as missing density or high density are observed, and the size of the spots is small but slightly larger. : Many large spot defects (loss of density, increase in density (+0.5)) are observed on the entire surface, and silver sludge adheres frequently. Evaluation criteria for failure of unexposed film 3: No silver sludge adheres and no emulsion remains 2 : A few emulsion residues remained in several places. 1: A large amount of silver sludge adhered, and emulsion residues were observed on the entire surface.
【0129】[0129]
【表1】 [Table 1]
【0130】表1記載の通り、本発明の請求項1の発明
の構成の場合に、濃度ムラ、画像欠陥、フィルム故障に
ついて改良効果が発揮されていることがわかる。As shown in Table 1, in the case of the structure according to the first aspect of the present invention, it can be seen that the effects of improving density unevenness, image defects, and film failure are exhibited.
【0131】即ち、本発明の請求項1の発明の構成の如
く、一般式(1)又は一般式(2)で表される化合物を
含有する感光材料を用いて、レダクトン類(特にエリソ
ルビン酸、アスコルビン酸類)を主薬とする現像液で処
理することにより、処理成分起因の付着による故障が無
く、濃度ムラを大きく抑止し画質が優れることがわか
る。That is, as in the constitution of the first aspect of the present invention, a reductone (particularly erythorbic acid, It can be seen that by processing with a developing solution containing (ascorbic acids) as the principal agent, there is no failure due to adhesion caused by processing components, density unevenness is largely suppressed, and image quality is excellent.
【0132】実施例2 一般式(1)または一般式(2)で表される化合物につ
いて、表2記載のように選択した以外は実施例1と同様
にしてハロゲン化銀写真感光材料を作製した。Example 2 A silver halide photographic light-sensitive material was prepared in the same manner as in Example 1, except that the compound represented by the general formula (1) or (2) was selected as shown in Table 2. .
【0133】また、定着剤の成分中のチオ硫酸アンモニ
ウム塩を、表2記載の種類のチオ硫酸塩と含有量のよう
に変更して用いた以外は実施例1と同様にして定着剤を
調製した。A fixing agent was prepared in the same manner as in Example 1 except that ammonium thiosulfate in the components of the fixing agent was used in the same manner as in the content of thiosulfate of the type shown in Table 2 except that the content was changed. .
【0134】TCX−201とSRX−101にて実施
例1と同様にランニングを実行し、それぞれ3ヶ月後、
6ヶ月後の画像欠陥、未露光フィルムの故障を評価し
た。Running was performed in the same manner as in Example 1 on TCX-201 and SRX-101.
Image defects after 6 months and failure of the unexposed film were evaluated.
【0135】以上の経過および結果を表2に示す。Table 2 shows the above progress and results.
【0136】[0136]
【表2】 [Table 2]
【0137】表2記載の通り、本発明の請求項2の発明
の構成の場合に、画像欠陥、未露光フィルムの故障の改
良に優れた効果を有していることがわかる。As shown in Table 2, it can be seen that the constitution of the second aspect of the present invention has an excellent effect of improving image defects and failure of unexposed films.
【0138】即ち、本発明の請求項2の発明の構成の如
く、一般式(1)又は一般式(2)で表される化合物を
含有する感光材料を用いて、アンモニウム塩を実質的に
含有しない現像液、定着液を用い処理することにより、
定着処理起因の故障が防止され画質が向上することがわ
かる。これは本発明の該化合物を含む感材とアンモニア
フリー処理液との組み合わせにより特に発揮された効果
によるものである。That is, as in the constitution of the second aspect of the present invention, a photosensitive material containing a compound represented by the general formula (1) or (2) is used to substantially contain an ammonium salt. By processing using a developer and a fixer that do not
It can be seen that a failure due to the fixing process is prevented and the image quality is improved. This is due to the effect particularly exhibited by the combination of the light-sensitive material containing the compound of the present invention and the ammonia-free processing solution.
【0139】実施例3 現像剤について、グルタルアルデヒド重亜硫酸ソーダ塩
の量を表3記載の如くに変更し、また、定着剤につい
て、固形硫酸アルミの量とpHを表3記載の如く変更し
た以外は実施例1と同様にして現像剤および定着剤を準
備した。Example 3 For the developer, the amount of glutaraldehyde sodium bisulfite was changed as shown in Table 3, and the amount of the solid aluminum sulfate and pH for the fixing agent were changed as shown in Table 3. In the same manner as in Example 1, a developer and a fixing agent were prepared.
【0140】TCX−201とSRX−101にて実施
例1と同様にランニングを実行しそれぞれ3ヶ月後、6
ヶ月後に同様な方法で画像欠陥を評価した。Running was performed in the same manner as in Example 1 on TCX-201 and SRX-101.
After a month, image defects were evaluated in the same manner.
【0141】更にランニングフィルムの処理済みのもの
を観察し、光沢ムラ、乾燥風にふかれ生ずるムラをも含
めた乾燥ムラの評価を下記基準にて目視で行った。Further, the processed running film was observed, and the drying unevenness including the unevenness caused by the gloss unevenness and the drying air was visually evaluated according to the following criteria.
【0142】〈乾燥ムラの評価〉 5:透過ムラも反射ムラも見られず、画質良好 4:透過ムラは無いが、極薄い濃度の反射ムラが微小な
範囲で見受けられる 3:透過ムラは無いが、反射ムラが部分的に認められ画
質上実用可能の下限 2:透過ムラは無いが、反射ムラが全面で明らかに認め
られる 1:透過ムラ、反射ムラが共に認められる 以上の経過および結果を表3に示す。<Evaluation of Drying Unevenness> 5: Neither transmission unevenness nor reflection unevenness was observed, and the image quality was good. 4: There was no transmission unevenness, but reflection unevenness with extremely low density was observed in a minute range. 3: No transmission unevenness was observed. However, reflection unevenness is partially observed, and the lower limit of practical use in terms of image quality 2: there is no transmission unevenness, but reflection unevenness is clearly observed over the entire surface. 1: transmission unevenness and reflection unevenness are both observed. It is shown in Table 3.
【0143】[0143]
【表3】 [Table 3]
【0144】表3記載の通り、本発明の請求項3の発明
の構成の場合に、画像欠陥、乾燥ムラの改良効果が優れ
ることがわかる。As shown in Table 3, it can be seen that in the case of the constitution of the third aspect of the present invention, the effect of improving image defects and uneven drying is excellent.
【0145】即ち、本発明の請求項3の発明の構成の如
く、一般式(1)又は一般式(2)で表される化合物を
含有する感光材料を用い、グルタルアルデヒド化合物を
実質的に含有しない現像液とアルミニウムイオンを実質
的に含まない定着液を用いて処理することにより、顕著
に結晶化、銀スラッジによるフィルム故障発生が解消さ
れ、乾燥に起因するムラも大きく良化し画質が向上する
ことがわかる。これは現像液、定着液の硬膜作用成分を
フリー化した(実質的に含有しない)ことで自己縮合、
副生成物発生などを解消し得て、一般式(1)又は一般
式(2)で表される化合物を含む感光材料との組み合わ
せにより特に発揮された効果によるものである。That is, as in the constitution of the third aspect of the present invention, a photosensitive material containing a compound represented by the general formula (1) or (2) is used, and a glutaraldehyde compound is substantially contained. By using a developing solution that does not contain aluminum oxide and a fixing solution that does not substantially contain aluminum ions, remarkable crystallization and film failure due to silver sludge are eliminated, unevenness due to drying is greatly improved, and image quality is improved. You can see that. This is because self-condensation is achieved by freeing (substantially not containing) the hardening component of the developer and fixer.
This is because the generation of by-products and the like can be eliminated, and the effect is particularly exhibited by the combination with the photosensitive material containing the compound represented by the general formula (1) or (2).
【0146】実施例4 現像剤と定着剤のホウ素化合物の量について、表4記載
のように変更した以外は実施例1と同様にして現像剤お
よび定着剤を調製した。Example 4 A developer and a fixing agent were prepared in the same manner as in Example 1 except that the amounts of the boron compound of the developer and the fixing agent were changed as shown in Table 4.
【0147】実施例1及び3と同様にして、TCX−2
01、SRX−101にて処理を行い濃度ムラ及び乾燥
ムラを評価した。In the same manner as in Examples 1 and 3, TCX-2
01 and SRX-101 to evaluate density unevenness and drying unevenness.
【0148】以上の経過および結果を表4に示す。Table 4 shows the above progress and results.
【0149】[0149]
【表4】 [Table 4]
【0150】表4記載の通り、本発明の請求項4の発明
の構成の場合に、濃度ムラ、乾燥ムラの改良効果に優れ
ることがわかる。As shown in Table 4, it can be seen that in the case of the constitution of the fourth aspect of the present invention, the effect of improving density unevenness and drying unevenness is excellent.
【0151】即ち、本発明の請求項4の発明の構成の如
く、一般式(1)又は一般式(2)で表される化合物を
含有する感光材料を用い、実質的にホウ素化合物を含有
しない現像液及び定着液で処理することにより、水質汚
濁防止法の規制に該当する物質を削減し水質良化に貢献
することはもちろんのこと、現像槽起因の濃度ムラ及び
乾燥ムラが良化し画質が向上することがわかる。これは
ホウ素化合物を含まない処理液と一般式(1)又は一般
式(2)で表される化合物との組み合わせにより特に発
揮された効果によるものである。That is, as in the constitution of the fourth aspect of the present invention, a light-sensitive material containing a compound represented by the general formula (1) or (2) is used and contains substantially no boron compound. By processing with a developer and a fixer, it is possible not only to reduce substances that fall under the regulations of the Water Pollution Control Law and contribute to improving water quality, but also to improve density unevenness and drying unevenness caused by the developing tank and improve image quality. It turns out that it improves. This is due to the effect particularly exhibited by the combination of the treatment solution containing no boron compound and the compound represented by the general formula (1) or (2).
【0152】実施例5 実施例1の定着剤の酢酸ソーダの量について、表5記載
の量に変更し、また、亜硫酸塩の種類と量について表5
記載のように変更した以外は実施例1と同様にして定着
剤を調製した。Example 5 The amount of sodium acetate as the fixing agent in Example 1 was changed to the amount shown in Table 5, and the type and amount of sulfite were changed as shown in Table 5.
A fixing agent was prepared in the same manner as in Example 1 except that the fixing agent was changed as described.
【0153】実施例1と同様にしてTCX−201、S
RX−101にて処理を行い画像欠陥を評価した。In the same manner as in Example 1, TCX-201, S
Processing was performed by RX-101, and image defects were evaluated.
【0154】更に定着性の尺度として未露光フィルムを
処理したときの残留銀の評価を下記に従い行った。Further, as a measure of fixability, the evaluation of residual silver when an unexposed film was processed was performed as follows.
【0155】〈残留銀の評価〉得られた未露光処理済み
試料に硫化ナトリウム2.6×10-3モル/L水溶液
(残留銀評価液)を一滴滴下し、3分放置後、液を拭き
取って常温常湿下で15時間放置した。その後、残留銀
評価液を滴下した部分と滴下しない部分のブルー光の透
過濃度をPDA−65型濃度計(コニカ(株)製)を用
いて測定し、その差をもって残留銀の目安とした。値が
0.03以下であれば問題ないが、それ以上であると銀
画像が経時で変色したり濃度低下を引き起こす。<Evaluation of Residual Silver> One drop of a 2.6 × 10 −3 mol / L aqueous solution of sodium sulfide (residual silver evaluation liquid) was dropped on the obtained unexposed sample, and after leaving for 3 minutes, the liquid was wiped off. And allowed to stand at room temperature and humidity for 15 hours. Thereafter, the transmission density of blue light in the portion where the residual silver evaluation solution was dropped and the portion where the remaining silver was not dropped was measured using a PDA-65 densitometer (manufactured by Konica Corporation), and the difference was used as a guide for the residual silver. If the value is 0.03 or less, there is no problem, but if it is more than 0.03, the silver image is discolored with time and the density is reduced.
【0156】以上の経過および結果を表5に示す。Table 5 shows the above progress and results.
【0157】[0157]
【表5】 [Table 5]
【0158】表5に記載の通り、本発明の請求項5の発
明の構成の場合に、画像欠陥の改良、定着性(残留銀の
改良)に優れることがわかる。As shown in Table 5, in the case of the constitution of the fifth aspect of the present invention, it can be seen that the image defect is improved and the fixability (the residual silver is improved) is excellent.
【0159】即ち、本発明の請求項5の発明の構成の如
く、一般式(1)又は一般式(2)で表される化合物を
含有する感光材料を用い、酢酸塩を実質的に含有せず亜
硫酸塩を0.5〜1.5mol/L含有する定着液で処
理することにより、処理液そのものの臭気性を良化する
ことはもちろんのこと、結晶化、銀スラッジ発生による
故障発生を解消し画質を大きく向上することがわかる。
又、定着性も向上した。これは従来定着バッファー剤と
して用いられてきた酢酸塩を亜硫酸塩に置き換えても、
一般式(1)又は一般式(2)で表される化合物と組み
合わせることにより特に発揮された効果によるものであ
る。That is, as in the constitution of the fifth aspect of the present invention, a photosensitive material containing a compound represented by the general formula (1) or (2) is used, and an acetate is substantially contained. Treatment with a fixing solution containing 0.5 to 1.5 mol / L of sulfite not only improves the odor of the processing solution itself, but also eliminates breakdown due to crystallization and silver sludge generation. It can be seen that the image quality is greatly improved.
Further, the fixing property was also improved. This is because even if acetate which has been used as a fixing buffer agent is replaced with sulfite,
This is due to the effect particularly exhibited by combining with the compound represented by the general formula (1) or (2).
【0160】実施例6 感光材料の保護層中の硬膜剤濃度とゼラチン量につい
て、現像液処理中及び定着液処理中の膨潤度が表6記載
のようになるように変更した以外は実施例1と同様にし
て感光材料を作製した。Example 6 The same procedure as in Example 6 was carried out except that the swelling degree during the processing with the developing solution and the processing with the fixing solution were changed as shown in Table 6 with respect to the concentration of the hardener and the amount of gelatin in the protective layer of the photographic material. In the same manner as in Example 1, a light-sensitive material was prepared.
【0161】実施例1、3と同様にしてTCX−20
1、SRX−101にて処理を行い画像欠陥、現像ム
ラ、乾燥ムラを評価した。In the same manner as in Examples 1 and 3, TCX-20
1. Processing was performed by SRX-101, and image defects, development unevenness, and drying unevenness were evaluated.
【0162】以上の経過および結果を表6に示す。Table 6 shows the above progress and results.
【0163】[0163]
【表6】 [Table 6]
【0164】表6に記載の通り、本発明の請求項6の発
明の構成の場合に、画像欠陥、現像ムラ、乾燥ムラに対
し優れた改良効果を示していることがわかる。As shown in Table 6, in the case of the constitution of the sixth aspect of the present invention, it can be seen that excellent improvement effects on image defects, development unevenness and drying unevenness are exhibited.
【0165】即ち、本発明の請求項6の発明の構成の如
く、一般式(1)又は一般式(2)で表される化合物を
含有する感光材料を用い、現像液処理中及び定着液処理
中の膨潤度を100〜200%になるように調整するこ
とにより、フィルム故障は防止され、現像ムラ及び乾燥
ムラ画質が大幅に向上することがわかる。銀スラッジ、
結晶化の発生も過酷な処理条件下においても減少してい
ることが認められる。これは膨潤度をコントロールでき
たことと、一般式(1)又は一般式(2)で表される化
合物と処理液との組み合わせにより特に発揮された効果
によるものである。That is, as in the constitution of the sixth aspect of the present invention, a photosensitive material containing a compound represented by the general formula (1) or (2) is used during processing in a developing solution and processing in a fixing solution. By adjusting the degree of swelling in the medium to 100 to 200%, it is found that the film failure is prevented and the image quality of development unevenness and drying unevenness is greatly improved. Silver sludge,
It can be seen that the occurrence of crystallization is reduced even under severe processing conditions. This is due to the fact that the degree of swelling could be controlled and the effect particularly exhibited by the combination of the compound represented by the general formula (1) or (2) and the treatment liquid.
【0166】[0166]
【発明の効果】本発明により、自動現像機でハロゲン化
銀写真感光材料を処理する際の、処理液低補充化、連続
処理の長期継続化、処理液疲労濃縮化等の過酷な処理条
件下で発生しやすくなる診断上致命的となる濃度ムラ、
銀スラッジや結晶付着による濃度欠陥の発生が改善され
たハロゲン化銀写真感光材料の処理方法を提供できる。According to the present invention, when processing a silver halide photographic light-sensitive material with an automatic processor, severe processing conditions such as low replenishment of processing solutions, long-term continuous processing, and concentration of processing solution fatigue. Density unevenness that is fatal in diagnosis, which is likely to occur in
It is possible to provide a method for processing a silver halide photographic material in which the occurrence of density defects due to silver sludge and crystal adhesion is improved.
Claims (7)
感光性親水性コロイド層を有するハロゲン化銀写真感光
材料を、少なくとも現像液、定着液及び水洗水を有する
自動現像機で処理する処理方法において、該感光材料が
下記一般式(1)または(2)で表される化合物を含有
し、かつ現像液がレダクトン類を含有することを特徴と
するハロゲン化銀写真感光材料の処理方法。 一般式(1) Rf−(O−Rf’)n−L1−Xm 〔式中、Rfは少なくとも1つのフッ素原子を含有する
脂肪族基を表し、Rf’は少なくとも1つのフッ素原子
を含有するアルキレン基を表し、n及びmはそれぞれ1
以上の整数を表し、L1は単なる結合手または連結基を
表し、Xはヒドロキシ基、アニオン性基またはカチオン
性基を表す。〕 一般式(2) 〔(Rf”O)n1−(PFC)−CO−Y1〕k−L2−
X’m1 〔式中、Rf”は炭素原子を1〜4個有するペルフルオ
ロアルキル基を表し、(PFC)はパーフルオロシクロ
アルキレン基を表し、Y1は酸素原子または窒素原子を
含有する連結基を表し、L2は単なる結合手または連結
基を示し、X’はアニオン性基、カチオン性基、ノニオ
ン性基または両性基を含む水可溶化極性基を表し、n1
は1〜5の整数を表し、kは1〜3の整数を表し、m1
は1〜5の整数を表す。〕1. A silver halide photographic material having a silver halide photographic emulsion layer and a non-photosensitive hydrophilic colloid layer on a support is processed by an automatic processor having at least a developing solution, a fixing solution and washing water. In the processing method, the light-sensitive material contains a compound represented by the following general formula (1) or (2), and the developer contains reductones. . Formula (1) Rf- 'in n -L 1 -X m [wherein, Rf represents an aliphatic group containing at least one fluorine atom, Rf (O-Rf)' is at least one fluorine atom N and m are each 1
L 1 represents a simple bond or a linking group, and X represents a hydroxy group, an anionic group or a cationic group. General formula (2) [(Rf "O) n1- (PFC) -CO-Y 1 ] k -L 2-
X ′ m1 [wherein, Rf ″ represents a perfluoroalkyl group having 1 to 4 carbon atoms, (PFC) represents a perfluorocycloalkylene group, and Y 1 represents a linking group containing an oxygen atom or a nitrogen atom. L 2 represents a simple bond or a linking group; X ′ represents a water-solubilizing polar group containing an anionic group, a cationic group, a nonionic group or an amphoteric group;
Represents an integer of 1 to 5, k represents an integer of 1 to 3, and m1
Represents an integer of 1 to 5. ]
感光性親水性コロイド層を有するハロゲン化銀写真感光
材料を、少なくとも現像液、定着液及び水洗水を有する
自動現像機で処理する処理方法において、該感光材料が
前記一般式(1)または(2)で表される化合物を含有
し、かつ現像液及び定着液が実質的にアンモニウム塩を
含有しないことを特徴とするハロゲン化銀写真感光材料
の処理方法。2. A silver halide photographic material having a silver halide photographic emulsion layer and a non-photosensitive hydrophilic colloid layer on a support is processed by an automatic developing machine having at least a developing solution, a fixing solution and washing water. In the processing method, the light-sensitive material contains the compound represented by the general formula (1) or (2), and the developing solution and the fixing solution contain substantially no ammonium salt. Processing method of photographic photosensitive material.
感光性親水性コロイド層を有するハロゲン化銀写真感光
材料を、少なくとも現像液、定着液及び水洗水を有する
自動現像機で処理する処理方法において、該感光材料が
前記一般式(1)または(2)で表される化合物を含有
し、かつ現像液がグルタルアルデヒド化合物を実質的に
含有せず、かつ定着液がアルミニウムイオンを実質的に
含有しないことを特徴とするハロゲン化銀写真感光材料
の処理方法。3. A silver halide photographic material having a silver halide photographic emulsion layer and a non-photosensitive hydrophilic colloid layer on a support is processed by an automatic processor having at least a developing solution, a fixing solution and washing water. In the processing method, the photosensitive material contains the compound represented by the general formula (1) or (2), the developer contains substantially no glutaraldehyde compound, and the fixer contains aluminum ions substantially. A method for processing a silver halide photographic light-sensitive material, characterized in that the light-sensitive material is not contained.
感光性親水性コロイド層を有するハロゲン化銀写真感光
材料を、少なくとも現像液、定着液及び水洗水を有する
自動現像機で処理する処理方法において、該感光材料が
前記一般式(1)または(2)で表される化合物を含有
し、かつ現像液及び定着液が実質的にホウ素化合物を含
有しないことを特徴とするハロゲン化銀写真感光材料の
処理方法。4. A silver halide photographic material having a silver halide photographic emulsion layer and a non-photosensitive hydrophilic colloid layer on a support is processed by an automatic processor having at least a developing solution, a fixing solution and washing water. In the processing method, the light-sensitive material contains a compound represented by the general formula (1) or (2), and the developing solution and the fixing solution contain substantially no boron compound. Processing method of photographic photosensitive material.
感光性親水性コロイド層を有するハロゲン化銀写真感光
材料を、少なくとも現像液、定着液及び水洗水を有する
自動現像機で処理する処理方法において、該感光材料が
前記一般式(1)または(2)で表される化合物を含有
し、かつ定着液が実質的に酢酸塩を含有せず、亜硫酸塩
を0.5〜1.5mol/L含有することを特徴とする
ハロゲン化銀写真感光材料の処理方法。5. A silver halide photographic material having a silver halide photographic emulsion layer and a non-photosensitive hydrophilic colloid layer on a support is processed by an automatic developing machine having at least a developing solution, a fixing solution and washing water. In the processing method, the light-sensitive material contains the compound represented by the general formula (1) or (2), and the fixer contains substantially no acetate, and contains 0.5 to 1. A method for processing a silver halide photographic light-sensitive material, characterized by containing 5 mol / L.
感光性親水性コロイド層を有するハロゲン化銀写真感光
材料を、少なくとも現像液、定着液及び水洗水を有する
自動現像機で処理する処理方法において、該感光材料が
前記一般式(1)または(2)で表される化合物を含有
し、該感光材料の現像液処理中及び定着液処理中の膨潤
度が100〜200%であることを特徴とするハロゲン
化銀写真感光材料の処理方法。6. A silver halide photographic material having a silver halide photographic emulsion layer and a non-photosensitive hydrophilic colloid layer on a support is processed by an automatic developing machine having at least a developing solution, a fixing solution and washing water. In the processing method, the light-sensitive material contains a compound represented by the general formula (1) or (2), and the swelling degree of the light-sensitive material during processing with a developing solution and processing with a fixing solution is 100 to 200%. A method for processing a silver halide photographic material.
固形定着剤を溶解したものであることを特徴とする請求
項1〜6のいずれか1項記載のハロゲン化銀写真感光材
料の処理方法。7. A developer and a fixer each comprising a solid developer,
The method for processing a silver halide photographic material according to any one of claims 1 to 6, wherein the solid fixing agent is dissolved.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2001125795A JP2002323728A (en) | 2001-04-24 | 2001-04-24 | Processing method for silver halide photographic sensitive material |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2001125795A JP2002323728A (en) | 2001-04-24 | 2001-04-24 | Processing method for silver halide photographic sensitive material |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JP2002323728A true JP2002323728A (en) | 2002-11-08 |
Family
ID=18974948
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2001125795A Pending JP2002323728A (en) | 2001-04-24 | 2001-04-24 | Processing method for silver halide photographic sensitive material |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP2002323728A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2005003075A1 (en) * | 2003-07-02 | 2005-01-13 | Daikin Industries, Ltd. | Fluoroalkyl carboxylic acid derivative, method for producing fluorine-containing polymer, and aqueous dispersion of fluorine-containing polymer |
-
2001
- 2001-04-24 JP JP2001125795A patent/JP2002323728A/en active Pending
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2005003075A1 (en) * | 2003-07-02 | 2005-01-13 | Daikin Industries, Ltd. | Fluoroalkyl carboxylic acid derivative, method for producing fluorine-containing polymer, and aqueous dispersion of fluorine-containing polymer |
| US7589234B2 (en) | 2003-07-02 | 2009-09-15 | Daikin Industries, Ltd. | Fluoroalkyl carboxylic acid derivative, method for producing fluorine-containing polymer, and aqueous dispersion of fluorine-containing polymer |
| US8198480B2 (en) | 2003-07-02 | 2012-06-12 | Daikin Industries, Ltd. | Fluoroalkyl carboxylic acid derivative, method for producing fluorine-containing polymer, and aqueous dispersion of fluorine-containing polymer |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPH0619527B2 (en) | Processing method of silver halide photographic light-sensitive material | |
| JP2565767B2 (en) | Processing method of silver halide photographic light-sensitive material | |
| JPH0648371B2 (en) | Processing method of silver halide photographic light-sensitive material for X-ray | |
| JP2964019B2 (en) | Method for developing silver halide photographic material and developer | |
| JP2002323728A (en) | Processing method for silver halide photographic sensitive material | |
| JPS63136043A (en) | Method for processing silver halide photographic sensitive material | |
| JPH0429135A (en) | Composition of development processing agent | |
| JPS63284546A (en) | Liquid fixer for silver halide photographic sensitive material which forbids generation of precipitate and gaseous acetic acid | |
| JP3248004B2 (en) | Processing method and processing agent for black-and-white silver halide photographic material | |
| JP2759280B2 (en) | Processing method of silver halide photographic material | |
| JP3248022B2 (en) | Processing method of silver halide photographic material | |
| JP3020101B2 (en) | Processing method of silver halide photographic material | |
| JP2003029384A (en) | Processing method for silver halide photographic sensitive material | |
| JP3422090B2 (en) | Silver halide photographic materials | |
| JP3320251B2 (en) | Developer for silver halide photographic material and processing method using the same | |
| JP2003173006A (en) | Developing solution for silver halide photographic sensitive material and processing method using the same | |
| JPH06236002A (en) | Processing agent for silver halide photographic sensitive material and processing method therefor | |
| JPH04234749A (en) | Silver halide photosensitive material | |
| JPH04143750A (en) | Development processing method for silver halide photographic sensitive material | |
| JP2001166407A (en) | Silver halide photographic sensitive material and processing method for same | |
| JPH0430158A (en) | Automatic development processing device and processing method | |
| JPH1097023A (en) | Silver halide photographic sensitive material and method for processing same | |
| JPH06242556A (en) | Silver halide photographic sensitive material and processing method for the same | |
| JPH1039446A (en) | Silver halide photographic sensitive material and its processing method | |
| JP2001242600A (en) | Method for processing silver halide photographic sensitive material |